Molecular	O
mechanisms	O
of	O
promoter	O
regulation	O
of	O
the	O
gp34	B-DNA
gene	I-DNA
that	O
is	O
trans-activated	O
by	O
an	O
oncoprotein	B-protein
Tax	I-protein
of	O
human	O
T	O
cell	O
leukemia	O
virus	O
type	O
I	O
.	O

We	O
investigated	O
the	O
molecular	O
mechanism	O
of	O
transcriptional	O
activation	O
of	O
the	O
gp34	B-DNA
gene	I-DNA
by	O
the	O
Tax	B-protein
oncoprotein	I-protein
of	O
human	O
T	O
cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
.	O

gp34	B-protein
is	O
a	O
type	B-protein
II	I-protein
transmembrane	I-protein
molecule	I-protein
belonging	O
to	O
the	O
tumor	O
necrosis	O
factor	O
family	O
and	O
is	O
constitutively	O
expressed	O
on	O
HTLV-I-producing	B-cell_type
cells	I-cell_type
but	O
not	O
normal	B-cell_type
resting	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

The	O
transcriptional	O
regulatory	O
region	O
of	O
the	O
gp34	B-DNA
gene	I-DNA
was	O
activated	O
by	O
HTLV-I	O
Tax	B-protein
in	O
the	O
human	B-cell_line
T	I-cell_line
cell	I-cell_line
line	I-cell_line
Jurkat	I-cell_line
,	O
in	O
which	O
endogenous	O
gp34	B-protein
is	O
induced	O
by	O
Tax	B-protein
.	O

Sequence	O
analysis	O
demonstrated	O
that	O
two	O
NF-kappaB-like	B-DNA
elements	I-DNA
(	O
1	O
and	O
2	O
)	O
were	O
present	O
in	O
the	O
regulatory	B-DNA
region	I-DNA
.	O

Both	O
NF-kappaB-like	B-DNA
elements	I-DNA
were	O
able	O
to	O
bind	O
to	O
NF-kappaB	B-protein
or	O
its	O
related	O
factor	O
(	O
s	O
)	O
in	O
a	O
Tax	B-protein
-dependent	O
manner	O
.	O

Chloramphenicol	B-protein
acetyltransferase	I-protein
assays	O
indicated	O
that	O
NF-kappaB-like	B-DNA
element	I-DNA
1	I-DNA
was	O
Tax	B-protein
-responsive	O
,	O
although	O
the	O
activity	O
was	O
lower	O
than	O
that	O
the	O
native	B-DNA
promoter	I-DNA
.	O

NF-kappaB	B-protein
-like	O
element	O
2	O
elevated	O
promoter	O
activity	O
when	O
combined	O
with	O
NF-kappaB-like	B-DNA
element	I-DNA
1	I-DNA
,	O
indicating	O
cooperative	O
function	O
of	O
the	O
elements	O
for	O
maximum	O
promoter	O
function	O
.	O

Unlike	O
typical	O
NF-kappaB	B-DNA
elements	I-DNA
,	O
the	O
NF-kappaB-like	B-DNA
elements	I-DNA
in	O
gp34	B-protein
were	O
not	O
activated	O
by	O
treatment	O
of	O
Jurkat	B-cell_line
cells	I-cell_line
with	O
phorbol	O
ester	O
despite	O
induction	O
of	O
the	O
NF-kappaB	B-protein
-like	O
binding	O
activity	O
.	O

Chloramphenicol	B-protein
acetyltransferase	I-protein
reporter	O
assays	O
using	O
the	O
region	O
upstream	O
of	O
the	O
NF-kappaB-like	B-DNA
elements	I-DNA
identified	O
an	O
upstream	O
region	O
that	O
reduced	O
transcription	O
from	O
cognate	B-DNA
and	I-DNA
noncognate	I-DNA
core	I-DNA
promoters	I-DNA
in	O
a	O
Tax-independent	O
manner	O
.	O

Our	O
results	O
imply	O
complex	O
regulation	O
of	O
expression	O
of	O
the	O
gp34	B-DNA
gene	I-DNA
and	O
suggest	O
implication	O
of	O
gp34	B-protein
in	O
proliferation	O
of	O
HTLV-I	O
infected	O
T	O
cells	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

273	NULL
,	NULL
No	NULL
.	NULL

23	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
5	NULL
,	NULL
pp	NULL
.	NULL

14119-14129	NULL
,	NULL
1998	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Molecular	NULL
Mechanisms	NULL
of	NULL
Promoter	NULL
Regulation	NULL
of	NULL
the	NULL
gp34	NULL
Gene	NULL
That	NULL
Is	NULL
Trans-activated	NULL
by	NULL
an	NULL
Oncoprotein	NULL
Tax	NULL
of	NULL
Human	NULL
T	NULL
Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
I*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
March	NULL
5	NULL
,	NULL
1998	NULL
)	NULL
Kiyoshi	NULL
Atsumi	NULL
Tsujimoto	NULL
$	NULL
,	NULL
Tomonori	NULL
Tsukaharaj§	NULL
,	NULL
Noboru	NULL
Numata1	NULL
,	NULL
Shigeto	NULL
Miural**	NULL
,	NULL
Kazuo	NULL
Sugamural	NULL
,	NULL
and	NULL
Masataka	NULL
Nakamurat	NULL
$	NULL
#	NULL
From	NULL
the	NULL
{	NULL
Human	NULL
Gene	NULL
Sciences	NULL
Center	NULL
and	NULL
the	NULL
§Department	NULL
of	NULL
Immunotherapeutics	NULL
,	NULL
Medical	NULL
Research	NULL
Division	NULL
,	NULL
Tokyo	NULL
Medical	NULL
and	NULL
Dental	NULL
University	NULL
,	NULL
1-5-45	NULL
Yushima	NULL
,	NULL
Bunkyo-ku	NULL
,	NULL
Tokyo	NULL
113-8510	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
Sendai	NULL
Municipal	NULL
Institute	NULL
of	NULL
Public	NULL
Health	NULL
,	NULL
2-5-10	NULL
Oroshimachi-higashi	NULL
,	NULL
Wakabayashi-ku	NULL
,	NULL
Sendai	NULL
983-0002	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Tohoku	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
2-1	NULL
Seiryo-machi	NULL
,	NULL
Aoba-ku	NULL
,	NULL
Sendai	NULL
980-8575	NULL
,	NULL
and	NULL
**Core	NULL
Research	NULL
for	NULL
Evolutional	NULL
Science	NULL
and	NULL
Technology	NULL
,	NULL
Japan	NULL
Science	NULL
and	NULL
Technology	NULL
Corp.	NULL
,	NULL
4-1-8	NULL
Honcho	NULL
,	NULL
Kawaguchi	NULL
332-0012	NULL
,	NULL
Japan	NULL
We	NULL
investigated	NULL
the	NULL
molecular	NULL
mechanism	NULL
of	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
by	NULL
the	NULL
Tax	NULL
oncoprotein	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-D.	NULL
gp34	NULL
is	NULL
a	NULL
type	NULL
II	NULL
transmembrane	NULL
molecule	NULL
belonging	NULL
to	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
family	NULL
and	NULL
is	NULL
constitutively	NULL
expressed	NULL
on	NULL
HTLV-I-producing	NULL
cells	NULL
but	NULL
not	NULL
normal	NULL
resting	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
transcriptional	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
was	NULL
activated	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
in	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
Jurkat	NULL
,	NULL
in	NULL
which	NULL
endogenous	NULL
gp34	NULL
is	NULL
induced	NULL
by	NULL
Tax	NULL
.	NULL

Sequence	NULL
analysis	NULL
demonstrated	NULL
that	NULL
two	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
(	NULL
1	NULL
and	NULL
2	NULL
)	NULL
were	NULL
present	NULL
in	NULL
the	NULL
regulatory	NULL
region	NULL
.	NULL

Both	NULL
NF-xB-like	NULL
elements	NULL
were	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
NF	NULL
-B	NULL
or	NULL
its	NULL
related	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
in	NULL
a	NULL
Tax-dependent	NULL
manner	NULL
.	NULL

Chloramphenicol	NULL
acetyltransferase	NULL
assays	NULL
indicated	NULL
that	NULL
NF-B-like	NULL
element	NULL
1	NULL
was	NULL
Tax-responsive	NULL
,	NULL
although	NULL
the	NULL
activity	NULL
was	NULL
lower	NULL
than	NULL
that	NULL
the	NULL
native	NULL
promoter	NULL
.	NULL

NF-B-like	NULL
element	NULL
2	NULL
elevated	NULL
promoter	NULL
activity	NULL
when	NULL
combined	NULL
with	NULL
NF-B-like	NULL
element	NULL
1	NULL
,	NULL
indicating	NULL
cooperative	NULL
function	NULL
of	NULL
the	NULL
elements	NULL
for	NULL
maximum	NULL
promoter	NULL
function	NULL
.	NULL

Unlike	NULL
typical	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
in	NULL
gp34	NULL
were	NULL
not	NULL
activated	NULL
by	NULL
treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
phorbol	NULL
ester	NULL
despite	NULL
induction	NULL
of	NULL
the	NULL
binding	NULL
activity	NULL
.	NULL

Chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
assays	NULL
using	NULL
the	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
identified	NULL
an	NULL
upstream	NULL
region	NULL
that	NULL
reduced	NULL
transcription	NULL
from	NULL
cognate	NULL
and	NULL
noncognate	NULL
core	NULL
promoters	NULL
in	NULL
a	NULL
Tax-indepen-dent	NULL
manner	NULL
.	NULL

Our	NULL
results	NULL
imply	NULL
complex	NULL
regulation	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
and	NULL
suggest	NULL
implication	NULL
of	NULL
gp34	NULL
in	NULL
proliferation	NULL
of	NULL
HTLV-I	NULL
infected	NULL
T	NULL
cells	NULL
.	NULL

Human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
is	NULL
an	NULL
etiologic	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
grant	NULL
for	NULL
Core	NULL
Research	NULL
for	NULL
Evolutional	NULL
Science	NULL
and	NULL
Technology	NULL
of	NULL
the	NULL
Japan	NULL
Science	NULL
and	NULL
Technology	NULL
Corp.	NULL
,	NULL
a	NULL
grant-in-aid	NULL
for	NULL
scientific	NULL
research	NULL
on	NULL
priority	NULL
areas	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
Sports	NULL
and	NULL
Culture	NULL
of	NULL
Japan	NULL
,	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Inamori	NULL
Foundation	NULL
,	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Mochida	NULL
Memorial	NULL
Medical	NULL
and	NULL
Pharmaceutical	NULL
Research	NULL
Foundation	NULL
,	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Ichiro	NULL
Kanehara	NULL
Foundation	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
DNA	NULL
Data	NULL
Bank	NULL
of	NULL
Japan	NULL
,	NULL
the	NULL
GenBank	NULL
``	NULL
``	NULL
/EBI	NULL
Data	NULL
Bank	NULL
with	NULL
accession	NULL
number	NULL
(	NULL
s	NULL
)	NULL
ABOO7839	NULL
.	NULL

{	NULL
f	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
81-8-5803-5795	NULL
;	NULL
Fax	NULL
:	NULL
81-8-5808-0234	NULL
;	NULL
E-mail	NULL
:	NULL
naka.gene	NULL
@	NULL
cmn.tmd.ac.jp	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
HTLV-I	NULL
,	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
;	NULL
IL-2	NULL
,	NULL
interleukin	NULL
2	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
agent	NULL
of	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
(	NULL
1-3	NULL
)	NULL
and	NULL
HTLV-I-associated	NULL
myelopathy/tropical	NULL
spastic	NULL
paraparesis	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

At	NULL
least	NULL
two	NULL
regulatory	NULL
molecules	NULL
,	NULL
Tax	NULL
and	NULL
Rex	NULL
,	NULL
are	NULL
encoded	NULL
by	NULL
the	NULL
HTLV-I	NULL
genome	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Tax	NULL
was	NULL
initially	NULL
found	NULL
to	NULL
be	NULL
a	NULL
trans-acting	NULL
transcriptional	NULL
activator	NULL
of	NULL
viral	NULL
gene	NULL
expression	NULL
(	NULL
7-9	NULL
)	NULL
and	NULL
was	NULL
subsequently	NULL
shown	NULL
to	NULL
induce	NULL
or	NULL
enhance	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
myriad	NULL
of	NULL
cellular	NULL
genes	NULL
,	NULL
most	NULL
of	NULL
which	NULL
are	NULL
implicated	NULL
in	NULL
cell	NULL
growth	NULL
.	NULL

These	NULL
include	NULL
genes	NULL
for	NULL
growth	NULL
factors	NULL
(	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
)	NULL
(	NULL
10-14	NULL
)	NULL
,	NULL
growth	NULL
factor	NULL
receptors	NULL
(	NULL
IL-2	NULL
receptor	NULL
«	NULL
and	NULL
y	NULL
sub-units	NULL
)	NULL
(	NULL
15-17	NULL
)	NULL
,	NULL
a	NULL
cytoplasmic	NULL
signal	NULL
mediator	NULL
(	NULL
lyn	NULL
)	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
nuclear	NULL
transcription	NULL
factors	NULL
(	NULL
c-fos	NULL
and	NULL
c-jun	NULL
)	NULL
(	NULL
19-21	NULL
)	NULL
.	NULL

Modulation	NULL
of	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
closely	NULL
associated	NULL
with	NULL
disease	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
mechanisms	NULL
of	NULL
Tax-induced	NULL
cellular	NULL
gene	NULL
expression	NULL
and	NULL
involvement	NULL
in	NULL
disease	NULL
onset	NULL
are	NULL
yet	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

Analyses	NULL
of	NULL
target	NULL
DNA	NULL
sequences	NULL
showed	NULL
that	NULL
three	NULL
enhancer	NULL
elements	NULL
that	NULL
bound	NULL
to	NULL
cyclic	NULL
AMP-responsive	NULL
element	NULL
binding	NULL
factor	NULL
(	NULL
CREB/ATF	NULL
)	NULL
(	NULL
22-25	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
26-28	NULL
)	NULL
,	NULL
and	NULL
serum-responsive	NULL
factor	NULL
(	NULL
29	NULL
)	NULL
were	NULL
activated	NULL
by	NULL
Tax	NULL
.	NULL

Tax	NULL
itself	NULL
can	NULL
not	NULL
bind	NULL
directly	NULL
to	NULL
target	NULL
DNA	NULL
sequences	NULL
,	NULL
although	NULL
it	NULL
activates	NULL
via	NULL
direct	NULL
association	NULL
with	NULL
the	NULL
cellular	NULL
transcription	NULL
factors	NULL
,	NULL
cyclic	NULL
AMP-responsive	NULL
element	NULL
binding	NULL
factor	NULL
,	NULL
NF-kB	NULL
and	NULL
serum-responsive	NULL
factor	NULL
(	NULL
29-32	NULL
)	NULL
,	NULL
and	NULL
an	NULL
inhibitor	NULL
of	NULL
NF-kB	NULL
,	NULL
I	NULL
«	NULL
B	NULL
(	NULL
83	NULL
,	NULL
34	NULL
)	NULL
.	NULL

We	NULL
cloned	NULL
a	NULL
cellular	NULL
gene	NULL
encoding	NULL
a	NULL
type	NULL
II	NULL
membrane	NULL
glycoprotein	NULL
,	NULL
named	NULL
gp34	NULL
,	NULL
which	NULL
was	NULL
expressed	NULL
on	NULL
HTLV-I-producing	NULL
cells	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

gp34	NULL
has	NULL
been	NULL
also	NULL
shown	NULL
to	NULL
bind	NULL
OXA40	NULL
,	NULL
a	NULL
marker	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
is	NULL
also	NULL
expressed	NULL
on	NULL
HTLV	NULL
cells	NULL
(	NULL
37-39	NULL
)	NULL
.	NULL

Apart	NULL
from	NULL
HTLV-I-producing	NULL
T	NULL
cells	NULL
,	NULL
gp34	NULL
and	NULL
OX40	NULL
are	NULL
also	NULL
expressed	NULL
on	NULL
activated	NULL
normal	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
388-40	NULL
)	NULL
.	NULL

Transcriptional	NULL
transactivation	NULL
of	NULL
the	NULL
gp34	NULL
and	NULL
OX40	NULL
genes	NULL
by	NULL
Tax	NULL
has	NULL
been	NULL
demonstrated	NULL
(	NULL
36	NULL
,	NULL
41	NULL
)	NULL
.	NULL

OX40	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
receptor	NULL
family	NULL
,	NULL
which	NULL
includes	NULL
FAS	NULL
and	NULL
CD40	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
,	NULL
and	NULL
gp34	NULL
belongs	NULL
to	NULL
the	NULL
TNF	NULL
family	NULL
(	NULL
39	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Functions	NULL
of	NULL
the	NULL
TNF	NULL
receptor/	NULL
TNF	NULL
and	NULL
FAS/FAS	NULL
ligand	NULL
systems	NULL
are	NULL
well	NULL
documented	NULL
with	NULL
regard	NULL
to	NULL
cell	NULL
proliferation	NULL
and	NULL
apoptosis	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Defects	NULL
of	NULL
the	NULL
CD40	NULL
ligand	NULL
are	NULL
associated	NULL
with	NULL
hyper-IgM	NULL
syndrome	NULL
(	NULL
45-47	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
unlike	NULL
those	NULL
molecules	NULL
,	NULL
gp34	NULL
and	NULL
OX40	NULL
are	NULL
not	NULL
detected	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
until	NULL
lymphocytes	NULL
are	NULL
activated	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
function	NULL
at	NULL
later	NULL
stages	NULL
of	NULL
lymphocyte	NULL
activation	NULL
and	NULL
proliferation	NULL
.	NULL

However	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
TPA	NULL
,	NULL
12-O-tetradecanoylphorbol-l8-acetate	NULL
;	NULL
PHA	NULL
,	NULL
phytohemaggluti-nin	NULL
;	NULL
CREB/ATF	NULL
,	NULL
cyclic	NULL
AMP	NULL
-responsive	NULL
element	NULL
binding	NULL
factor	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
PIPES	NULL
,	NULL
1,4-piperazinediethane-sulfonic	NULL
acid	NULL
.	NULL

14119	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
14120	NULL
function	NULL
of	NULL
the	NULL
gp34/0X40	NULL
system	NULL
.	NULL

Recent	NULL
studies	NULL
indicate	NULL
that	NULL
both	NULL
gp34	NULL
and	NULL
OX40	NULL
transmit	NULL
signals	NULL
into	NULL
the	NULL
cytoplasm	NULL
(	NULL
38-40	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Unlike	NULL
other	NULL
cellular	NULL
genes	NULL
transactivated	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
,	NULL
gp34	NULL
is	NULL
not	NULL
induced	NULL
on	NULL
T	NULL
cells	NULL
by	NULL
stimulation	NULL
with	NULL
mitogens	NULL
,	NULL
phorbol	NULL
ester	NULL
,	NULL
or	NULL
IL-2	NULL
(	NULL
35	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
imply	NULL
that	NULL
the	NULL
gp34/0X40	NULL
system	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
growth	NULL
regulation	NULL
of	NULL
T	NULL
cells	NULL
during	NULL
immune	NULL
responses	NULL
and	NULL
in	NULL
growth	NULL
of	NULL
HTLV-I-infected	NULL
T	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
elucidation	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
gp34	NULL
and	NULL
OX40	NULL
expression	NULL
would	NULL
be	NULL
useful	NULL
in	NULL
understanding	NULL
normal	NULL
and	NULL
cancerous	NULL
proliferation	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
mechanism	NULL
of	NULL
Tax-induced	NULL
transcriptional	NULL
regulation	NULL
of	NULL
gp34	NULL
.	NULL

Tax-induced	NULL
gp34	NULL
transactivation	NULL
was	NULL
mediated	NULL
through	NULL
a	NULL
unique	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
that	NULL
was	NULL
not	NULL
activated	NULL
by	NULL
phorbol	NULL
ester	NULL
.	NULL

We	NULL
detected	NULL
a	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
that	NULL
suppressed	NULL
transcription	NULL
from	NULL
cognate	NULL
and	NULL
noncognate	NULL
core	NULL
promoters	NULL
.	NULL

The	NULL
array	NULL
of	NULL
these	NULL
regions	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
strict	NULL
and	NULL
complex	NULL
regulation	NULL
of	NULL
gp34	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cells-TL-Mor	NULL
(	NULL
49	NULL
)	NULL
and	NULL
MT-2	NULL
(	NULL
50	NULL
)	NULL
are	NULL
HTLV-I-producing	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

Jurkat	NULL
(	NULL
51	NULL
)	NULL
is	NULL
a	NULL
human	NULL
acute	NULL
lymphocytic	NULL
leukemia	NULL
T	NULL
cell	NULL
line	NULL
negative	NULL
for	NULL
HTLV-I	NULL
.	NULL

JPX-9	NULL
is	NULL
a	NULL
Jurkat	NULL
subline	NULL
that	NULL
stably	NULL
carries	NULL
Tax	NULL
expression	NULL
plasmid	NULL
,	NULL
in	NULL
which	NULL
expression	NULL
of	NULL
Tax	NULL
is	NULL
inducible	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
CdCl	NULL
,	NULL
(	NULL
20	NULL
,	NULL
52	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
10	NULL
mM	NULL
L-glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
at	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
in	NULL
air	NULL
.	NULL

DNA	NULL
Cloning	NULL
and	NULL
Sequencing-A	NULL
human	NULL
genomic	NULL
DNA	NULL
library	NULL
was	NULL
constructed	NULL
by	NULL
introduction	NULL
of	NULL
Sau8AI	NULL
partially	NULL
digested	NULL
genomic	NULL
DNA	NULL
from	NULL
normal	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
phage	NULL
vector	NULL
EMBL3	NULL
.	NULL

The	NULL
library	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
plaques	NULL
)	NULL
was	NULL
screened	NULL
by	NULL
plaque	NULL
hybridization	NULL
using	NULL
the	NULL
5'-most	NULL
EcoRI	NULL
fragment	NULL
of	NULL
gp34	NULL
cDNA	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Nucleotide	NULL
sequencing	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
dideoxy	NULL
chain	NULL
termination	NULL
method	NULL
using	NULL
Sequenase	NULL
2.0	NULL
(	NULL
United	NULL
States	NULL
Biochemicals	NULL
)	NULL
according	NULL
to	NULL
the	NULL
protocol	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

S1	NULL
Nuclease	NULL
Mapping	NULL
and	NULL
Primer	NULL
Extension-Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
MT-2	NULL
and	NULL
Jurkat	NULL
cells	NULL
by	NULL
the	NULL
guanidium	NULL
thiocyanate	NULL
method	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
58	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
for	NULL
S1	NULL
mapping	NULL
was	NULL
the	NULL
499-base	NULL
pair	NULL
(	NULL
bp	NULL
)	NULL
Alul	NULL
genomic	NULL
DNA	NULL
fragment	NULL
.	NULL

The	NULL
end-labeled	NULL
Alul	NULL
fragment	NULL
was	NULL
annealed	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
RNA	NULL
in	NULL
20	NULL
ul	NULL
of	NULL
solution	NULL
containing	NULL
80	NULL
%	NULL
formamide	NULL
,	NULL
20	NULL
mM	NULL
PIPES	NULL
(	NULL
pH	NULL
6.4	NULL
)	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
200	NULL
mM	NULL
NaCl	NULL
at	NULL
52	NULL
°C	NULL
for	NULL
3	NULL
h	NULL
after	NULL
initial	NULL
incubation	NULL
at	NULL
85	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
annealed	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
S1	NULL
nuclease	NULL
(	NULL
100	NULL
units	NULL
)	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
solution	NULL
containing	NULL
270	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mm	NULL
ZnSO	NULL
,	NULL
,	NULL
30	NULL
mM	NULL
sodium	NULL
acetate	NULL
(	NULL
pH	NULL
4.6	NULL
)	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
80	NULL
min	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
phenol/chloroform	NULL
extraction	NULL
.	NULL

DNA	NULL
was	NULL
ethanol-precipitated	NULL
and	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
in	NULL
an	NULL
8	NULL
%	NULL
acrylamide	NULL
sequencing	NULL
gel	NULL
with	NULL
7	NULL
M	NULL
urea	NULL
.	NULL

The	NULL
primer	NULL
used	NULL
for	NULL
primer	NULL
extension	NULL
was	NULL
a	NULL
30-mer	NULL
oligonucleotide	NULL
(	NULL
CTTGTTCCTCTCGAATCTTGGCCTGGCTGC	NULL
)	NULL
corresponding	NULL
to	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
minus	NULL
strand	NULL
of	NULL
the	NULL
S1	NULL
mapping	NULL
probe	NULL
.	NULL

End-labeled	NULL
primer	NULL
was	NULL
annealed	NULL
to	NULL
20	NULL
pg	NULL
of	NULL
RNA	NULL
in	NULL
30	NULL
ul	NULL
of	NULL
solution	NULL
containing	NULL
80	NULL
%	NULL
formamide	NULL
,	NULL
100	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
120	NULL
mM	NULL
KCl	NULL
,	NULL
and	NULL
20	NULL
mM	NULL
MgC	NULL
]	NULL
,	NULL
at	NULL
30	NULL
°C	NULL
for	NULL
8	NULL
h	NULL
after	NULL
initial	NULL
incubation	NULL
at	NULL
85	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
annealed	NULL
product	NULL
was	NULL
ethanol-precipitated	NULL
and	NULL
resuspended	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
solution	NULL
containing	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
,	NULL
60	NULL
mm	NULL
KCl	NULL
,	NULL
10	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
dNTPs	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
1	NULL
unit/ul	NULL
human	NULL
placental	NULL
ribonuclease	NULL
inhibitor	NULL
.	NULL

The	NULL
extension	NULL
reaction	NULL
was	NULL
initiated	NULL
by	NULL
adding	NULL
50	NULL
units	NULL
of	NULL
reverse	NULL
transcriptase	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
2	NULL
h.	NULL
The	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
along	NULL
with	NULL
the	NULL
S1	NULL
mapping	NULL
product	NULL
.	NULL

Size	NULL
markers	NULL
were	NULL
sequencing	NULL
ladders	NULL
of	NULL
the	NULL
gp34	NULL
genomic	NULL
DNA	NULL
fragment	NULL
using	NULL
a	NULL
17-mer	NULL
primer	NULL
corresponding	NULL
to	NULL
the	NULL
5-end	NULL
of	NULL
the	NULL
30-mer	NULL
oligonucleotide	NULL
used	NULL
for	NULL
primer	NULL
extension	NULL
analysis	NULL
.	NULL

Plasmids-The	NULL
9-kbp	NULL
fragment	NULL
(	NULL
-9000	NULL
)	NULL
-Avall	NULL
(	NULL
+27	NULL
)	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
was	NULL
inserted	NULL
in	NULL
front	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
in	NULL
a	NULL
reporter	NULL
plasmid	NULL
,	NULL
pSVOCAT	NULL
(	NULL
54	NULL
)	NULL
,	NULL
to	NULL
generate	NULL
pGP	NULL
(	NULL
-9000	NULL
)	NULL
CAT	NULL
.	NULL

Deletion	NULL
mutants	NULL
of	NULL
both	NULL
5'-	NULL
and	NULL
3'-ends	NULL
of	NULL
the	NULL
genomic	NULL
fragment	NULL
were	NULL
generated	NULL
by	NULL
digestion	NULL
from	NULL
restriction	NULL
sites	NULL
with	NULL
exonuclease	NULL
III	NULL
and	NULL
mung	NULL
bean	NULL
nuclease	NULL
.	NULL

The	NULL
5	NULL
deletion	NULL
mutants	NULL
were	NULL
derived	NULL
from	NULL
pGP	NULL
(	NULL
-92000	NULL
)	NULL
CAT	NULL
.	NULL

The	NULL
3	NULL
'	NULL
deletion	NULL
mutants	NULL
were	NULL
prepared	NULL
by	NULL
insertion	NULL
of	NULL
a	NULL
series	NULL
of	NULL
3	NULL
'	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
-823	NULL
to	NULL
-54	NULL
fragment	NULL
into	NULL
the	NULL
-31	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
,	NULL
pGP	NULL
(	NULL
-81	NULL
)	NULL
CAT	NULL
,	NULL
which	NULL
contained	NULL
the	NULL
58-bp	NULL
(	NULL
-81	NULL
to	NULL
+27	NULL
)	NULL
genomic	NULL
fragment	NULL
.	NULL

Plasmids	NULL
with	NULL
mutant	NULL
fragments	NULL
were	NULL
named	NULL
according	NULL
to	NULL
the	NULL
numbers	NULL
of	NULL
the	NULL
5'-	NULL
or	NULL
8'-end	NULL
of	NULL
the	NULL
fragments	NULL
.	NULL

pGP	NULL
(	NULL
-31	NULL
)	NULL
CAT	NULL
was	NULL
also	NULL
used	NULL
as	NULL
a	NULL
backbone	NULL
vector	NULL
to	NULL
be	NULL
introduced	NULL
with	NULL
HTLV-I	NULL
Tax-mediated	NULL
Activation	NULL
of	NULL
the	NULL
gp34	NULL
Gene	NULL
Promoter	NULL
the	NULL
-100	NULL
to	NULL
-54	NULL
fragment	NULL
,	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
,	NULL
and	NULL
the	NULL
HTLV-I	NULL
enhancer	NULL
fragment	NULL
.	NULL

The	NULL
-100	NULL
to	NULL
-54	NULL
fragment	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
pGP	NULL
(	NULL
-31	NULL
)	NULL
CAT	NULL
plasmid	NULL
in	NULL
single	NULL
form	NULL
(	NULL
pGP	NULL
(	NULL
-100~-54	NULL
)	NULL
CAT	NULL
)	NULL
and	NULL
four	NULL
tandem	NULL
repeat	NULL
form	NULL
(	NULL
pGP	NULL
(	NULL
-100~-54	NULL
)	NULL
x4CAT	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
NF-xB-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
pGP	NULL
(	NULL
-31	NULL
)	NULL
CAT	NULL
plasmid	NULL
in	NULL
single	NULL
and	NULL
four	NULL
tandem	NULL
repeat	NULL
forms	NULL
,	NULL
yielding	NULL
pGPxB1CAT	NULL
,	NULL
pGP	NULL
«	NULL
B2CAT	NULL
,	NULL
pGP	NULL
«	NULL
B1X4CAT	NULL
,	NULL
and	NULL
pGPrB2X4	NULL
CAT	NULL
,	NULL
respectively	NULL
.	NULL

pHE	NULL
(	NULL
-31	NULL
)	NULL
CAT	NULL
is	NULL
a	NULL
derivative	NULL
of	NULL
the	NULL
pGP	NULL
(	NULL
-31	NULL
)	NULL
CAT	NULL
plasmid	NULL
carrying	NULL
the	NULL
267-bp	NULL
HTLV-I	NULL
enhancer	NULL
fragment	NULL
(	NULL
55	NULL
)	NULL
.	NULL

pdHE4	NULL
is	NULL
a	NULL
CAT	NULL
plasmid	NULL
containing	NULL
the	NULL
HTLV-I	NULL
core	NULL
promoter	NULL
(	NULL
55	NULL
)	NULL
.	NULL

pdHExB-4	NULL
carries	NULL
four	NULL
tandemly	NULL
repeated	NULL
SV40	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
pdHE4	NULL
(	NULL
56	NULL
)	NULL
.	NULL

pdHE	NULL
(	NULL
-823~-54	NULL
)	NULL
CAT	NULL
is	NULL
a	NULL
derivative	NULL
of	NULL
the	NULL
pdHE4	NULL
having	NULL
the	NULL
-828	NULL
to	NULL
-54	NULL
fragment	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
promoter	NULL
.	NULL

pMAXneo	NULL
is	NULL
a	NULL
Tax	NULL
expression	NULL
vector	NULL
in	NULL
which	NULL
the	NULL
Tax	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
mouse	NULL
metallothionein	NULL
promoter	NULL
,	NULL
whereas	NULL
pMAXneo/M	NULL
is	NULL
a	NULL
nonfunctional	NULL
Tax	NULL
mutant	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Reexamination	NULL
of	NULL
the	NULL
DNA	NULL
sequence	NULL
for	NULL
the	NULL
Tax	NULL
mutant	NULL
demonstrated	NULL
that	NULL
the	NULL
mutant	NULL
gene	NULL
has	NULL
a	NULL
3-base	NULL
insertion	NULL
at	NULL
the	NULL
Miul	NULL
site	NULL
in	NULL
the	NULL
coding	NULL
region	NULL
,	NULL
rather	NULL
than	NULL
a	NULL
4-base	NULL
insertion	NULL
as	NULL
reported	NULL
initially	NULL
(	NULL
55	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
mutant	NULL
with	NULL
an	NULL
additional	NULL
Arg	NULL
residue	NULL
between	NULL
amino	NULL
acids	NULL
62	NULL
and	NULL
63	NULL
.	NULL

Tax	NULL
mutants	NULL
TaxM22	NULL
,	NULL
Tax703	NULL
,	NULL
and	NULL
Taxd8	NULL
,	NULL
which	NULL
are	NULL
not	NULL
effective	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
serum-responsive	NULL
factor	NULL
,	NULL
and	NULL
CREB/ATF	NULL
binding	NULL
sites	NULL
,	NULL
respectively	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
82	NULL
,	NULL
57	NULL
,	NULL
58	NULL
)	NULL
.	NULL

Wild	NULL
type	NULL
Tax	NULL
and	NULL
these	NULL
Tax	NULL
mutant	NULL
genes	NULL
were	NULL
cloned	NULL
into	NULL
pHBAPr-1-neo	NULL
,	NULL
which	NULL
has	NULL
a	NULL
B-actin	NULL
promoter	NULL
(	NULL
59	NULL
)	NULL
.	NULL

CAT	NULL
Assay-Plasmid	NULL
DNA	NULL
was	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
55	NULL
)	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
shown	NULL
as	NULL
percent	NULL
acetylation	NULL
,	NULL
and	NULL
transactivation	NULL
was	NULL
expressed	NULL
as	NULL
fold	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
with	NULL
pMAXneo	NULL
compared	NULL
with	NULL
that	NULL
with	NULL
pMAXneo/M	NULL
.	NULL

In	NULL
CAT	NULL
assays	NULL
with	NULL
12-O-tetradecanoylphorbol-18-acetate	NULL
(	NULL
TPA	NULL
)	NULL
,	NULL
TPA	NULL
was	NULL
added	NULL
to	NULL
cells	NULL
transfected	NULL
with	NULL
CAT	NULL
plasmids	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
20	NULL
nM	NULL
,	NULL
12	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
a	NULL
further	NULL
36	NULL
h.	NULL
We	NULL
also	NULL
compared	NULL
CAT	NULL
activity	NULL
with	NULL
TPA	NULL
to	NULL
that	NULL
without	NULL
TPA	NULL
.	NULL

All	NULL
CAT	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
at	NULL
least	NULL
three	NULL
times	NULL
in	NULL
duplicate	NULL
.	NULL

Repeated	NULL
assays	NULL
showed	NULL
similar	NULL
results	NULL
,	NULL
and	NULL
representative	NULL
data	NULL
are	NULL
presented	NULL
.	NULL

Gel	NULL
Shift	NULL
Assay-The	NULL
gel	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
56	NULL
)	NULL
.	NULL

DNA	NULL
probes	NULL
were	NULL
end-labeled	NULL
with	NULL
polynucleotide	NULL
kinase	NULL
and	NULL
[	NULL
y-*	NULL
``	NULL
P	NULL
]	NULL
ATP	NULL
(	NULL
5000	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
TL-Mor	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
JPX-9	NULL
cells	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
as	NULL
probes	NULL
and	NULL
competitors	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
bases-100~-54	NULL
.	NULL

5'-cgatGAAAGAAAGTAAAGGGGAAATTCAGATTAGTCACAAAGAAGTTICCCCat-3	NULL
'	NULL
3'-taCTTICITICATITCCCCTTITAAGTCTAATCAGTGTITICTITICAAGGGGtage-5	NULL
'	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
.	NULL

5'-cgatAAAGGGGAAATTCAGat-3	NULL
'	NULL
3'-taTTTCCCCTTTAAGTCtage-5	NULL
'	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
mutant	NULL
.	NULL

5'-cgatAAAGGAACAATTCAGat-3	NULL
'	NULL
3'-taTTTCCTTGTTAAGTCtage-5	NULL
'	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
2	NULL
.	NULL

5'-cgatGCGGGGGAACTTCTTat-3	NULL
'	NULL
3'-taCGCCCCCTTGAAGAAtage-5	NULL
'	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
2	NULL
mutant	NULL
.	NULL

5'-cgatGCGGGAACACTTCTTage-5	NULL
'	NULL
3'-taCGCCCTTGTGAAGAAtage-5	NULL
'	NULL
Typical	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

5'-cgatAGAGGGGACTTTCCGat-3	NULL
'	NULL
3'-taTCTCCCCTGAAAGGCtage-5	NULL
'	NULL
HTLV-I	NULL
C26	NULL
.	NULL

5'-cgatCCGGGAAGCCACCGGAACCACCTATTat-3	NULL
``	NULL
3'-taGGCCCTTCGGTGGCCTTGGTGGATAAtage-5	NULL
'	NULL
HTLV-I	NULL
21-bp	NULL
motif	NULL
.	NULL

5'-cgatAAGGCTCTGACGTCTCCCCCCat-3	NULL
'	NULL
3'-taTTCCGAGACTGCAGAGGGGGGtage-5	NULL
'	NULL
Antibodies	NULL
used	NULL
for	NULL
gel	NULL
mobility	NULL
supershift	NULL
assay	NULL
were	NULL
anti-NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
sc-372X	NULL
)	NULL
,	NULL
anti-NF-xB	NULL
p50	NULL
(	NULL
sc-114X	NULL
)	NULL
,	NULL
anti-c-Rel	NULL
(	NULL
sc-1827X	NULL
)	NULL
,	NULL
anti-RelB	NULL
(	NULL
sc-226X	NULL
)	NULL
,	NULL
and	NULL
anti-NF-	NULL
«	NULL
B	NULL
p52	NULL
(	NULL
sc-298X	NULL
)	NULL
antibodies	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
HTLV-I	NULL
Tax-mediated	NULL
Activation	NULL
of	NULL
the	NULL
gp34	NULL
Gene	NULL
Promoter	NULL
RESULTS	NULL
Cloning	NULL
of	NULL
the	NULL
gp34	NULL
Regulatory	NULL
Region-In	NULL
order	NULL
to	NULL
analyze	NULL
the	NULL
regulatory	NULL
mechanism	NULL
of	NULL
gp34	NULL
gene	NULL
transcription	NULL
,	NULL
we	NULL
cloned	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
.	NULL

A	NULL
human	NULL
genomic	NULL
DNA	NULL
library	NULL
constructed	NULL
with	NULL
EMBL3	NULL
was	NULL
screened	NULL
with	NULL
the	NULL
5'-most	NULL
EcoRI	NULL
fragment	NULL
of	NULL
the	NULL
gp34	NULL
cDNA	NULL
.	NULL

Several	NULL
positive	NULL
clones	NULL
were	NULL
identified	NULL
,	NULL
and	NULL
one	NULL
clone	NULL
,	NULL
which	NULL
contained	NULL
sequences	NULL
9	NULL
kbp	NULL
upstream	NULL
of	NULL
the	NULL
ATG	NULL
initiation	NULL
codon	NULL
for	NULL
gp34	NULL
,	NULL
was	NULL
further	NULL
analyzed	NULL
.	NULL

The	NULL
promoter	NULL
activity	NULL
of	NULL
this	NULL
region	NULL
was	NULL
examined	NULL
by	NULL
CAT	NULL
assays	NULL
.	NULL

The	NULL
9-kbp	NULL
5'-flanking	NULL
fragment	NULL
was	NULL
isolated	NULL
and	NULL
ligated	NULL
to	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
examined	NULL
with	NULL
or	NULL
without	NULL
a	NULL
Tax	NULL
expression	NULL
vector	NULL
,	NULL
pMAXneo	NULL
,	NULL
in	NULL
the	NULL
human	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
9-kbp	NULL
fragment	NULL
showed	NULL
little	NULL
or	NULL
no	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Tax	NULL
expression	NULL
induced	NULL
promoter	NULL
activity	NULL
of	NULL
this	NULL
fragment	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
was	NULL
present	NULL
in	NULL
this	NULL
region	NULL
,	NULL
and	NULL
its	NULL
activity	NULL
was	NULL
dependent	NULL
on	NULL
Tax	NULL
.	NULL

Experiments	NULL
using	NULL
5	NULL
'	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
9-kbp	NULL
fragment	NULL
showed	NULL
that	NULL
most	NULL
,	NULL
if	NULL
not	NULL
all	NULL
,	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
850-bp	NULL
KpnI-Avall	NULL
fragment	NULL
in	NULL
the	NULL
9-kbp	NULL
5	NULL
'	NULL
-flanking	NULL
region	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
850-bp	NULL
fragment	NULL
was	NULL
then	NULL
determined	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
was	NULL
contained	NULL
in	NULL
this	NULL
fragment	NULL
,	NULL
S1	NULL
mapping	NULL
and	NULL
primer	NULL
extension	NULL
analyses	NULL
were	NULL
performed	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
an	NULL
HTLV-I	NULL
infected	NULL
T	NULL
cell	NULL
line	NULL
(	NULL
TL-Mor	NULL
)	NULL
and	NULL
an	NULL
HTLV-I	NULL
[	NULL
-unrelated	NULL
T	NULL
cell	NULL
line	NULL
(	NULL
Jurkat	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
hybridized	NULL
with	NULL
an	NULL
S1	NULL
mapping	NULL
probe	NULL
of	NULL
the	NULL
497-bp	NULL
Alul	NULL
genomic	NULL
fragment	NULL
.	NULL

A	NULL
224-base	NULL
fragment	NULL
protected	NULL
from	NULL
nuclease	NULL
digestion	NULL
was	NULL
detected	NULL
using	NULL
RNA	NULL
from	NULL
TL-Mor	NULL
but	NULL
not	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

A	NULL
product	NULL
of	NULL
the	NULL
same	NULL
size	NULL
was	NULL
observed	NULL
using	NULL
TL-Mor	NULL
but	NULL
not	NULL
Jurkat	NULL
RNA	NULL
by	NULL
primer	NULL
extension	NULL
analysis	NULL
using	NULL
a	NULL
30-mer	NULL
primer	NULL
with	NULL
the	NULL
same	NULL
5'-end	NULL
as	NULL
the	NULL
minus	NULL
strand	NULL
of	NULL
the	NULL
81	NULL
probe	NULL
.	NULL

These	NULL
results	NULL
showed	NULL
that	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
was	NULL
located	NULL
154	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
ATG	NULL
initiation	NULL
codon	NULL
and	NULL
that	NULL
most	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
resided	NULL
in	NULL
the	NULL
region	NULL
extending	NULL
from	NULL
-824	NULL
to	NULL
+27	NULL
.	NULL

Sequence	NULL
analysis	NULL
showed	NULL
that	NULL
there	NULL
were	NULL
two	NULL
NF-KB	NULL
site-like	NULL
sequences	NULL
(	NULL
-87	NULL
to	NULL
-77	NULL
and	NULL
-64	NULL
to	NULL
-54	NULL
)	NULL
and	NULL
one	NULL
AP-1	NULL
site-like	NULL
sequence	NULL
(	NULL
-74	NULL
to	NULL
-68	NULL
)	NULL
between	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B-like	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Although	NULL
a	NULL
typical	NULL
TATA	NULL
box	NULL
sequence	NULL
was	NULL
not	NULL
found	NULL
around	NULL
30	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
TTAAA	NULL
sequence	NULL
located	NULL
at	NULL
-29	NULL
might	NULL
be	NULL
TATA-related	NULL
.	NULL

Promoter	NULL
Activities	NULL
of	NULL
Deletion	NULL
Mutants-In	NULL
order	NULL
to	NULL
examine	NULL
the	NULL
function	NULL
of	NULL
each	NULL
subregion	NULL
in	NULL
the	NULL
regulatory	NULL
region	NULL
,	NULL
a	NULL
series	NULL
of	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
regulatory	NULL
region	NULL
was	NULL
generated	NULL
,	NULL
and	NULL
the	NULL
mutants	NULL
were	NULL
assayed	NULL
for	NULL
their	NULL
promoter	NULL
activities	NULL
with	NULL
or	NULL
without	NULL
Tax	NULL
.	NULL

A	NULL
5'-end	NULL
deletion	NULL
(	NULL
up	NULL
to	NULL
-31	NULL
)	NULL
of	NULL
the	NULL
-824	NULL
to	NULL
+27	NULL
fragment	NULL
completely	NULL
abolished	NULL
Tax	NULL
responsiveness	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

This	NULL
-31	NULL
mutant	NULL
retained	NULL
the	NULL
TATA-related	NULL
sequence	NULL
TTAAA	NULL
and	NULL
was	NULL
thought	NULL
to	NULL
contain	NULL
the	NULL
core	NULL
promoter	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
addition	NULL
of	NULL
the	NULL
HTLV-I	NULL
enhancer	NULL
to	NULL
the	NULL
-31	NULL
mutant	NULL
restored	NULL
Tax	NULL
responsiveness	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
core	NULL
promoter	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
seemed	NULL
to	NULL
be	NULL
Tax-independent	NULL
,	NULL
and	NULL
the	NULL
upstream	NULL
region	NULL
appeared	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
Tax-dependent	NULL
activation	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
-31	NULL
mutant	NULL
linked	NULL
to	NULL
the	NULL
-823	NULL
to	NULL
-54	NULL
fragment	NULL
exhibited	NULL
the	NULL
same	NULL
CAT	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
Tax	NULL
as	NULL
did	NULL
the	NULL
-823	NULL
mutant	NULL
.	NULL

Combination	NULL
of	NULL
the	NULL
-823	NULL
to	NULL
-54	NULL
fragment	NULL
with	NULL
the	NULL
HTLV-I	NULL
core	NULL
promoter	NULL
also	NULL
showed	NULL
Tax-dependent	NULL
activation	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
region	NULL
between	NULL
-823	NULL
and	NULL
-54	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
mediates	NULL
transactivation	NULL
by	NULL
Tax	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
-31	NULL
mutant	NULL
showed	NULL
higher	NULL
CAT	NULL
activity	NULL
than	NULL
the	NULL
-823	NULL
mutant	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Tax	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
-823	NULL
to	NULL
-54	NULL
fragment	NULL
,	NULL
when	NULL
linked	NULL
to	NULL
the	NULL
HTLV-I	NULL
core	NULL
promoter	NULL
,	NULL
significantly	NULL
reduced	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Tax	NULL
,	NULL
although	NULL
14121	NULL
it	NULL
endowed	NULL
Tax-dependent	NULL
activation	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
a	NULL
region	NULL
enhancing	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
Tax	NULL
,	NULL
there	NULL
is	NULL
a	NULL
region	NULL
in	NULL
the	NULL
-823	NULL
to	NULL
-54	NULL
fragment	NULL
that	NULL
suppresses	NULL
basal	NULL
transcription	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Tax	NULL
.	NULL

The	NULL
Tax-responsive	NULL
region	NULL
was	NULL
further	NULL
localized	NULL
by	NULL
CAT	NULL
assays	NULL
using	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
5'-flanking	NULL
fragment	NULL
.	NULL

A	NULL
mutant	NULL
with	NULL
a	NULL
-106	NULL
deletion	NULL
at	NULL
the	NULL
5'-end	NULL
retained	NULL
Tax	NULL
responsiveness	NULL
although	NULL
it	NULL
showed	NULL
an	NULL
increased	NULL
inherent	NULL
CAT	NULL
activity	NULL
without	NULL
Tax	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
an	NULL
element	NULL
responsible	NULL
for	NULL
Tax-dependent	NULL
activation	NULL
is	NULL
retained	NULL
in	NULL
a	NULL
region	NULL
downstream	NULL
of	NULL
-106	NULL
and	NULL
that	NULL
the	NULL
suppressive	NULL
activity	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
region	NULL
upstream	NULL
of	NULL
-106	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
3'-border	NULL
of	NULL
the	NULL
Tax-responsive	NULL
region	NULL
,	NULL
a	NULL
set	NULL
of	NULL
3	NULL
'	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
-823	NULL
to	NULL
-54	NULL
fragment	NULL
were	NULL
linked	NULL
to	NULL
the	NULL
-31	NULL
mutant	NULL
and	NULL
assayed	NULL
for	NULL
their	NULL
Tax-dependent	NULL
activation	NULL
.	NULL

Addition	NULL
of	NULL
the	NULL
-823	NULL
to	NULL
-54	NULL
fragment	NULL
to	NULL
the	NULL
-31	NULL
core	NULL
CAT	NULL
vector	NULL
gave	NULL
as	NULL
high	NULL
an	NULL
activation	NULL
(	NULL
more	NULL
than	NULL
30-fold	NULL
induction	NULL
)	NULL
in	NULL
response	NULL
to	NULL
Tax	NULL
as	NULL
did	NULL
the	NULL
native	NULL
-823	NULL
to	NULL
+27	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

A	NULL
3	NULL
'	NULL
mutant	NULL
deleted	NULL
to	NULL
-57	NULL
exhibited	NULL
a	NULL
profoundly	NULL
reduced	NULL
response	NULL
to	NULL
Tax	NULL
with	NULL
induction	NULL
of	NULL
only	NULL
7.7-fold	NULL
.	NULL

Further	NULL
deletion	NULL
to	NULL
-118	NULL
completely	NULL
abolished	NULL
Tax-dependent	NULL
activation	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
a	NULL
Tax-responsive	NULL
element	NULL
is	NULL
present	NULL
in	NULL
the	NULL
region	NULL
between	NULL
-106	NULL
and	NULL
-54	NULL
.	NULL

Interestingly	NULL
,	NULL
all	NULL
3	NULL
'	NULL
deletion	NULL
mutants	NULL
exhibited	NULL
reduced	NULL
CAT	NULL
activity	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
-31	NULL
mutant	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

This	NULL
implies	NULL
that	NULL
suppressive	NULL
activity	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
region	NULL
upstream	NULL
of	NULL
-118	NULL
,	NULL
consistent	NULL
with	NULL
observations	NULL
from	NULL
the	NULL
5	NULL
deletion	NULL
mutants	NULL
.	NULL

Tax-responsive	NULL
Element-To	NULL
identify	NULL
an	NULL
element	NULL
responsible	NULL
for	NULL
Tax-dependent	NULL
activation	NULL
,	NULL
an	NULL
isolated	NULL
sequence	NULL
from	NULL
-106	NULL
to	NULL
-54	NULL
was	NULL
assayed	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
mediate	NULL
Tax-dependent	NULL
activation	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
spanning	NULL
bases	NULL
-100	NULL
to	NULL
-54	NULL
was	NULL
synthesized	NULL
and	NULL
linked	NULL
to	NULL
the	NULL
-31	NULL
mutant	NULL
as	NULL
either	NULL
a	NULL
single	NULL
copy	NULL
or	NULL
four	NULL
tandem	NULL
repeats	NULL
in	NULL
the	NULL
sense	NULL
orientation	NULL
,	NULL
yielding	NULL
pGP	NULL
(	NULL
-100~-54	NULL
)	NULL
CAT	NULL
and	NULL
pGP	NULL
(	NULL
-100~-54	NULL
)	NULL
x4CAT	NULL
,	NULL
respectively	NULL
.	NULL

Reporter	NULL
plasmids	NULL
were	NULL
introduced	NULL
into	NULL
Jurkat	NULL
cells	NULL
and	NULL
examined	NULL
for	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
Tax	NULL
.	NULL

Introduction	NULL
of	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
synthetic	NULL
sequence	NULL
reproducibly	NULL
induced	NULL
slight	NULL
but	NULL
significant	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
Tax	NULL
with	NULL
a	NULL
4-fold	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Four	NULL
tandem	NULL
repeats	NULL
mediated	NULL
profound	NULL
(	NULL
up	NULL
to	NULL
90-fold	NULL
)	NULL
Tax-dependent	NULL
activation	NULL
.	NULL

Introduction	NULL
of	NULL
three	NULL
tandem	NULL
repeats	NULL
in	NULL
the	NULL
antisense	NULL
orientation	NULL
induced	NULL
6-fold	NULL
activation	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
sequence	NULL
from	NULL
-100	NULL
to	NULL
-54	NULL
contains	NULL
an	NULL
element	NULL
(	NULL
s	NULL
)	NULL
that	NULL
functions	NULL
as	NULL
an	NULL
enhancer	NULL
and	NULL
is	NULL
transactivated	NULL
by	NULL
Tax	NULL
.	NULL

Sequence	NULL
analysis	NULL
revealed	NULL
that	NULL
there	NULL
were	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site-related	NULL
sequences	NULL
in	NULL
the	NULL
region	NULL
.	NULL

These	NULL
sequences	NULL
were	NULL
therefore	NULL
possible	NULL
candidates	NULL
for	NULL
the	NULL
Tax-responsive	NULL
element	NULL
.	NULL

We	NULL
thus	NULL
examined	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
sequences	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
Tax	NULL
.	NULL

The	NULL
wild	NULL
type	NULL
oligonucleotides	NULL
(	NULL
NF	NULL
-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

1B	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
and	NULL
their	NULL
mutants	NULL
(	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
and	NULL
2	NULL
mutants	NULL
)	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
-31	NULL
core	NULL
CAT	NULL
plasmid	NULL
in	NULL
the	NULL
sense	NULL
orientation	NULL
in	NULL
single	NULL
copy	NULL
and	NULL
four	NULL
tandem	NULL
repeat	NULL
form	NULL
.	NULL

Introduction	NULL
of	NULL
one	NULL
copy	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
induced	NULL
little	NULL
or	NULL
no	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
Tax	NULL
.	NULL

The	NULL
tandem	NULL
repeat	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
induced	NULL
14-fold	NULL
activation	NULL
.	NULL

Mutation	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
abolished	NULL
Tax-dependent	NULL
activation	NULL
.	NULL

Unexpectedly	NULL
,	NULL
four	NULL
tandem	NULL
copies	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
2	NULL
exhibited	NULL
CAT	NULL
activity	NULL
as	NULL
low	NULL
as	NULL
its	NULL
corresponding	NULL
mutant	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
.	NULL

These	NULL
results	NULL
showed	NULL
that	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
is	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
a	NULL
Tax-responsive	NULL
element	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
CAT	NULL
activity	NULL
induced	NULL
by	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
was	NULL
less	NULL
than	NULL
that	NULL
induced	NULL
by	NULL
the	NULL
original	NULL
-100	NULL
to	NULL
-54	NULL
fragment	NULL
,	NULL
suggesting	NULL
that	NULL
NF-	NULL
«	NULL
B-like	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
14122	NULL
HTLV-I	NULL
Tax-mediated	NULL
Activation	NULL
of	NULL
the	NULL
gp34	NULL
Gene	NULL
Promoter	NULL
Sau3Al	NULL
Avail	NULL
Kpnl	NULL
Ays	NULL
)	NULL
SaugAl	NULL
Fold	NULL
//	NULL
1	NULL
I	NULL
ivi	NULL
ﬁ	NULL
//	NULL
CAT	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
Activation	NULL
Exon	NULL
1	NULL
Tax	NULL
0	NULL
5	NULL
10	NULL
15	NULL
-3000	NULL
|	NULL
--	NULL
/Z	NULL
CAT	NULL
5.4	NULL
+	NULL
-2700	NULL
I	NULL
CAT	NULL
19.1	NULL
+	NULL
-823	NULL
|	NULL
--	NULL
--	NULL
-H_	NULL
CAT	NULL
R	NULL
28.6	NULL
B	NULL
L823	NULL
GGT	NULL
ACCTGGTGTC	NULL
TATTGATAGA	NULL
-800	NULL
ATACCCTTAC	NULL
TTTCCAAGTT	NULL
CTGAGGCCAG	NULL
CCACAACCTC	NULL
AAAGAAAGAA	NULL
ATAATCTTCA	NULL
AAGCTTATTT	NULL
ACATCTATTC	NULL
ATTTGTTCAT	NULL
TCATGGAAAA	NULL
-700	NULL
ATTATGTACG	NULL
GGAAAAATGT	NULL
GAAGTGGAAG	NULL
GAAAGGAGAC	NULL
AAGGATACCC	NULL
TTCTGCTTCT	NULL
TTTCTGGTAT	NULL
GCAGAAAATT	NULL
AATCATATAA	NULL
TTGTTTATTG	NULL
-600	NULL
AATTTGCCTC	NULL
AAAGGGTTAA	NULL
ATGAGAGAAA	NULL
GATTGCAAGT	NULL
CCATCTAACA	NULL
CAGTGTCTGA	NULL
CACATAGTAA	NULL
ATGCTTCCAA	NULL
AAGGTAGTTT	NULL
ATTTTTATGC	NULL
-500	NULL
AATAGACTAC	NULL
AACCAAGGAT	NULL
CTCTCCTTTA	NULL
CCTTCTGCAT	NULL
GACCCAGTGT	NULL
CCTATTTTCT	NULL
TGTTTTGTCT	NULL
TTTTCATTCA	NULL
AGAATGATCT	NULL
GTGTGTGCTT	NULL
-400	NULL
TCTTTCTGAA	NULL
TCTGTGAGAG	NULL
GGGTTCAATG	NULL
TTTAGTTACA	NULL
TAGTAAAGTG	NULL
CAGATAAGAA	NULL
CCTTGGGCCA	NULL
GCATTTCCCC	NULL
TAAATCTTTT	NULL
CTATGATTTA	NULL
-300	NULL
AGACACCTTG	NULL
GGGAAGGGAT	NULL
ATATGAGCTG	NULL
CTACATTAAC	NULL
GGATGATGAT	NULL
TTTTATCTTT	NULL
ACCAAGTGAC	NULL
CCACAATTTG	NULL
TTACTGGTGC	NULL
AATAAGTTAA	NULL
-200	NULL
GAAAATAGCA	NULL
TACTTTTATG	NULL
ACTGTCATTT	NULL
CACAGTCACT	NULL
CAAATCAGAA	NULL
CTGGAATGTC	NULL
ACAAAAACAA	NULL
CTCCCTGTTA	NULL
GCCCAGAGGA	NULL
AAAAAAAAAA	NULL
xB	NULL
like	NULL
1	NULL
AP-1	NULL
like	NULL
xB	NULL
like	NULL
2	NULL
-100	NULL
GAAAGAAAGT	NULL
AAAGGGGAAA	NULL
TTCAGATIAG	NULL
TCACAAMGAA	NULL
GTTCCCCCGC	NULL
CTGCCTGCAA	NULL
AAGTTGCAGC	NULL
GTIAAAACTG	NULL
AGAGAGTCCG	NULL
CTTTGCTCTT	NULL
+1	NULL
TCAATCGCCT	NULL
TTTATCTCTG	NULL
GCCCTGGGAC	NULL
CTTTGCCTAT	NULL
TTTCTGATTG	NULL
ATAGGCTTTG	NULL
TTTTGTCTTA	NULL
CCTCCTTCTT	NULL
TCTGGGAAAA	NULL
CTCAGTTTTA	NULL
+100	NULL
_	NULL
TCGCACGTTC	NULL
CCCTTTTCCA	NULL
TATCTTCATC	NULL
TTCCCTCTAC	NULL
CCAGATTGTG	NULL
AAGATG	NULL
C	NULL
1	NULL
23	NULL
4	NULL
PF	NULL
a	NULL
OL-	NULL
«	NULL
1	NULL
|	NULL
+	NULL
OL+	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
.	NULL

A	NULL
,	NULL
Tax-dependent	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
carrying	NULL
the	NULL
9-kbp	NULL
Seu8AI-Avall	NULL
,	NULL
2.7-kbp	NULL
Avall-Avall	NULL
,	NULL
and	NULL
850-bp	NULL
KpnI-Avall	NULL
fragments	NULL
with	NULL
and	NULL
without	NULL
pMAXneo	NULL
and	NULL
examined	NULL
for	NULL
CAT	NULL
activity	NULL
after	NULL
86	NULL
h	NULL
of	NULL
culture	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
uM	NULL
CdCl	NULL
,	NULL
.	NULL

Restriction	NULL
sites	NULL
in	NULL
the	NULL
5'-flanking	NULL
region	NULL
,	NULL
first	NULL
exon	NULL
,	NULL
and	NULL
translation	NULL
initiation	NULL
codon	NULL
are	NULL
indicated	NULL
.	NULL

B	NULL
,	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
from	NULL
the	NULL
KpnI	NULL
site	NULL
to	NULL
the	NULL
initiation	NULL
codon	NULL
(	NULL
underlined	NULL
)	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
transcription	NULL
initiation	NULL
site	NULL
determined	NULL
from	NULL
S1	NULL
nuclease	NULL
mapping	NULL
and	NULL
primer	NULL
extension	NULL
is	NULL
numbered	NULL
+1	NULL
.	NULL

NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
are	NULL
boxed	NULL
.	NULL

The	NULL
AP-1	NULL
site-like	NULL
sequence	NULL
is	NULL
double	NULL
underlined	NULL
.	NULL

The	NULL
TATA-like	NULL
sequence	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
dashed	NULL
underline	NULL
.	NULL

C	NULL
,	NULL
transcriptional	NULL
start	NULL
site	NULL
.	NULL

RNA	NULL
from	NULL
Jurkat	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
and	NULL
MT-2	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
cells	NULL
was	NULL
subjected	NULL
to	NULL
S1	NULL
nuclease	NULL
mapping	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
and	NULL
primer	NULL
extension	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Size	NULL
markers	NULL
are	NULL
sequencing	NULL
ladders	NULL
of	NULL
the	NULL
-flanking	NULL
region	NULL
using	NULL
the	NULL
same	NULL
primer	NULL
as	NULL
for	NULL
primer	NULL
extension	NULL
.	NULL

element	NULL
1	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
full	NULL
Tax-mediated	NULL
activation	NULL
and	NULL
that	NULL
another	NULL
sequence	NULL
or	NULL
proper	NULL
organization	NULL
of	NULL
elements	NULL
in	NULL
the	NULL
region	NULL
may	NULL
be	NULL
required	NULL
for	NULL
full	NULL
activity	NULL
(	NULL
see	NULL
below	NULL
and	NULL
under	NULL
``	NULL
Discussion	NULL
``	NULL
)	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
introduced	NULL
a	NULL
mutation	NULL
into	NULL
either	NULL
element	NULL
1	NULL
or	NULL
element	NULL
2	NULL
in	NULL
the	NULL
-100	NULL
to	NULL
-54	NULL
fragment	NULL
.	NULL

Neither	NULL
CAT	NULL
reporter	NULL
constructs	NULL
with	NULL
element	NULL
1	NULL
mutant	NULL
or	NULL
element	NULL
2	NULL
mutant	NULL
were	NULL
activated	NULL
by	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
element	NULL
2	NULL
is	NULL
critically	NULL
involved	NULL
in	NULL
Tax-induced	NULL
full	NULL
activation	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
with	NULL
the	NULL
-823	NULL
to	NULL
-69	NULL
fragment	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
HTLV-I	NULL
Tax-mediated	NULL
Activation	NULL
of	NULL
the	NULL
gp34	NULL
Gene	NULL
Promoter	NULL
CAT	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
n	NULL
etustion	NULL
0	NULL
5	NULL
10	NULL
15	NULL
i	NULL
-323	NULL
.	NULL

C.	NULL
T_	NULL
I	NULL
16.9	NULL
516.	NULL
mms	NULL
(	NULL
__	NULL
I	NULL
15.6	NULL
--	NULL
_	NULL
mm	NULL
I	NULL
163.	NULL
me-	NULL
___	NULL
8.6	NULL
__J	NULL
f	NULL
im	NULL
]	NULL
-106.	NULL
meum	NULL
4.5	NULL
om	NULL
31	NULL
@	NULL
{	NULL
___	NULL
|	NULL
1.4	NULL
_.	NULL
HTLV-I	NULL
Enh	NULL
.	NULL

.	NULL

-	NULL
6.4	NULL
oo	NULL
HTLV-I	NULL
Core	NULL
Prom	NULL
.	NULL

.	NULL

(	NULL
eee	NULL
1.2	NULL
ooo	NULL
54	NULL
[	NULL
d	NULL
823.	NULL
memes	NULL
7777777777727	NULL
)	NULL
|	NULL
e	NULL
3.2	NULL
54	NULL
I	NULL
823	NULL
_—	NULL
--	NULL
|	NULL
pe	NULL
os	NULL
-57	NULL
I	NULL
sommes	NULL
-	NULL
is-ma	NULL
7.7	NULL
-69	NULL
___	NULL
|	NULL
L___________	NULL
L	NULL
a	NULL
3.0	NULL
~89	NULL
-	NULL
I	NULL
CI	NULL
-Ta	NULL
=	NULL
l—	NULL
I	NULL
-	NULL
Tax	NULL
2-1	NULL
118	NULL
I	NULL
mmm	NULL
--	NULL
in	NULL
|	NULL
___	NULL
|	NULL
_	NULL
1.0	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Analysis	NULL
of	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
regulatory	NULL
region	NULL
.	NULL

Progressive	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
gp34	NULL
promoter	NULL
are	NULL
schematically	NULL
illustrated	NULL
.	NULL

Fragments	NULL
of	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
gp34	NULL
gene	NULL
are	NULL
shown	NULL
as	NULL
solid	NULL
boxes	NULL
.	NULL

The	NULL
HTLV-I	NULL
enhancer	NULL
and	NULL
HTLV-I	NULL
core	NULL
promoter	NULL
are	NULL
indicated	NULL
by	NULL
§	NULL
and	NULL
&	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
reporter	NULL
plasmids	NULL
were	NULL
co-transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
with	NULL
or	NULL
without	NULL
the	NULL
Tax	NULL
expression	NULL
vector	NULL
pMAXneo	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Tax	NULL
mutants	NULL
differing	NULL
in	NULL
properties	NULL
in	NULL
activation	NULL
of	NULL
target	NULL
elements	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
CREB/ATF	NULL
,	NULL
and	NULL
serum-responsive	NULL
factor	NULL
binding	NULL
sites	NULL
,	NULL
were	NULL
examined	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
activate	NULL
the	NULL
gp34	NULL
promoter	NULL
.	NULL

The	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
(	NULL
-823	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
along	NULL
with	NULL
Tax	NULL
mutant	NULL
expression	NULL
vectors	NULL
TaxM22	NULL
(	NULL
M22	NULL
)	NULL
,	NULL
Tax703	NULL
(	NULL
703	NULL
)	NULL
,	NULL
and	NULL
Taxd3	NULL
(	NULL
d3	NULL
)	NULL
,	NULL
which	NULL
are	NULL
not	NULL
effective	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
NF-KB	NULL
,	NULL
serum-responsive	NULL
factor	NULL
,	NULL
and	NULL
CREB/ATF	NULL
binding	NULL
sites	NULL
,	NULL
respectively	NULL
.	NULL

Tax	NULL
mutants	NULL
703	NULL
and	NULL
d3	NULL
,	NULL
but	NULL
not	NULL
M22	NULL
,	NULL
were	NULL
able	NULL
to	NULL
activate	NULL
the	NULL
gp34	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
suggesting	NULL
the	NULL
implication	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
pathway	NULL
in	NULL
gp34	NULL
gene	NULL
expression	NULL
.	NULL

Cellular	NULL
Factor	NULL
(	NULL
s	NULL
)	NULL
Bound	NULL
to	NULL
the	NULL
Tax-responsive	NULL
Element-To	NULL
investigate	NULL
the	NULL
cellular	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
Tax-responsive	NULL
element	NULL
and	NULL
to	NULL
examine	NULL
effects	NULL
of	NULL
Tax	NULL
on	NULL
such	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
,	NULL
we	NULL
performed	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
HTLV-I-expressing	NULL
TL-Mor	NULL
cells	NULL
and	NULL
HTLV	NULL
-I-unrelated	NULL
Jurkat	NULL
cells	NULL
.	NULL

When	NULL
the	NULL
-100	NULL
to	NULL
-54	NULL
fragment	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
a	NULL
clear	NULL
shifted	NULL
band	NULL
was	NULL
observed	NULL
with	NULL
TL-Mor	NULL
nuclear	NULL
extract	NULL
but	NULL
not	NULL
Jurkat	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

The	NULL
shifted	NULL
complex	NULL
was	NULL
specific	NULL
to	NULL
the	NULL
fragment	NULL
because	NULL
complex	NULL
formation	NULL
was	NULL
competed	NULL
away	NULL
by	NULL
addition	NULL
of	NULL
excess	NULL
cold	NULL
probe	NULL
but	NULL
not	NULL
by	NULL
unrelated	NULL
competitors	NULL
such	NULL
as	NULL
the	NULL
21-bp	NULL
motif	NULL
sequence	NULL
in	NULL
the	NULL
HTLV-I	NULL
enhancer	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
addition	NULL
of	NULL
either	NULL
a	NULL
typical	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sequence	NULL
or	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
abolished	NULL
complex	NULL
formation	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
that	NULL
interacts	NULL
with	NULL
the	NULL
-100	NULL
to	NULL
-54	NULL
fragment	NULL
is	NULL
an	NULL
NF-	NULL
«	NULL
B-related	NULL
mole-cule	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
this	NULL
complex	NULL
formation	NULL
was	NULL
also	NULL
competed	NULL
away	NULL
by	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
2	NULL
,	NULL
which	NULL
was	NULL
not	NULL
Tax-responsive	NULL
by	NULL
itself	NULL
in	NULL
CAT	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
were	NULL
similarly	NULL
performed	NULL
using	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
as	NULL
probes	NULL
.	NULL

Combination	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
and	NULL
TL-Mor	NULL
nuclear	NULL
extract	NULL
,	NULL
but	NULL
not	NULL
Jurkat	NULL
nuclear	NULL
extract	NULL
,	NULL
resulted	NULL
in	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

This	NULL
binding	NULL
14123	NULL
was	NULL
competed	NULL
away	NULL
by	NULL
the	NULL
typical	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
and	NULL
also	NULL
by	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
2	NULL
.	NULL

NF-	NULL
«	NULL
B-like	NULL
element	NULL
2	NULL
essentially	NULL
showed	NULL
the	NULL
same	NULL
pattern	NULL
of	NULL
complex	NULL
formation	NULL
as	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Mutant	NULL
sequences	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
were	NULL
not	NULL
effective	NULL
in	NULL
complex	NULL
formation	NULL
even	NULL
with	NULL
TL-Mor	NULL
nuclear	NULL
extract	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

That	NULL
binding	NULL
activity	NULL
was	NULL
observed	NULL
only	NULL
with	NULL
nuclear	NULL
extracts	NULL
of	NULL
TL-Mor	NULL
indicates	NULL
that	NULL
the	NULL
binding	NULL
activity	NULL
was	NULL
Tax-induced	NULL
.	NULL

This	NULL
notion	NULL
was	NULL
confirmed	NULL
by	NULL
observations	NULL
with	NULL
the	NULL
Tax-inducible	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
JPX-9	NULL
,	NULL
in	NULL
which	NULL
induction	NULL
of	NULL
Tax	NULL
expression	NULL
resulted	NULL
in	NULL
induction	NULL
of	NULL
complex	NULL
formation	NULL
with	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Tax	NULL
induces	NULL
gp34	NULL
gene	NULL
expression	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
through	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
to	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
in	NULL
the	NULL
enhancer	NULL
.	NULL

Bands	NULL
representing	NULL
the	NULL
complex	NULL
between	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
and	NULL
NF-	NULL
«	NULL
B-like	NULL
factors	NULL
showed	NULL
very	NULL
close	NULL
migration	NULL
by	NULL
electrophoresis	NULL
to	NULL
that	NULL
with	NULL
the	NULL
typical	NULL
NF-kB	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
to	NULL
identify	NULL
factors	NULL
bound	NULL
to	NULL
gp34	NULL
gene	NULL
NF	NULL
-	NULL
«	NULL
B-like	NULL
elements	NULL
,	NULL
we	NULL
performed	NULL
gel	NULL
shift	NULL
assay	NULL
using	NULL
antibodies	NULL
specific	NULL
for	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
.	NULL

Supershifts	NULL
were	NULL
seen	NULL
with	NULL
anti-p65	NULL
,	NULL
anti-p50	NULL
,	NULL
and	NULL
anti-RelB	NULL
antibodies	NULL
in	NULL
both	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
,	NULL
illustrating	NULL
that	NULL
the	NULL
complex	NULL
with	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
contains	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
RelB	NULL
,	NULL
as	NULL
shown	NULL
with	NULL
the	NULL
consensus	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

46	NULL
)	NULL
.	NULL

Because	NULL
a	NULL
typical	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
is	NULL
activated	NULL
by	NULL
TPA	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
in	NULL
the	NULL
gp34	NULL
promoter	NULL
region	NULL
was	NULL
affected	NULL
by	NULL
TPA	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
and	NULL
,	NULL
12	NULL
h	NULL
later	NULL
,	NULL
treated	NULL
with	NULL
20	NULL
ny	NULL
TPA	NULL
.	NULL

The	NULL
four	NULL
tandem	NULL
repeat	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
TPA	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
responsiveness	NULL
of	NULL
the	NULL
same	NULL
fragment	NULL
to	NULL
Tax	NULL
,	NULL
although	NULL
treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
TPA	NULL
induced	NULL
complex	NULL
formation	NULL
with	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
in	NULL
gel	NULL
shift	NULL
assay	NULL
similar	NULL
to	NULL
TL-Mor	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
,	NULL
the	NULL
native	NULL
gp34	NULL
promoter	NULL
fragment	NULL
(	NULL
-823	NULL
to	NULL
+27	NULL
)	NULL
and	NULL
the	NULL
-100	NULL
to	NULL
-54	NULL
fragment	NULL
with	NULL
the	NULL
-31	NULL
core	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
plasmid	NULL
did	NULL
not	NULL
show	NULL
appreciable	NULL
elevation	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
TPA	NULL
.	NULL

Upstream	NULL
Suppressive	NULL
Region-Several	NULL
lines	NULL
of	NULL
evidence	NULL
as	NULL
shown	NULL
above	NULL
suggest	NULL
that	NULL
there	NULL
is	NULL
a	NULL
negatively	NULL
acting	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
.	NULL

To	NULL
examine	NULL
this	NULL
notion	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
isolated	NULL
upstream	NULL
sequence	NULL
demonstrated	NULL
suppressive	NULL
effects	NULL
.	NULL

The	NULL
upstream	NULL
fragment	NULL
spanning	NULL
bases	NULL
-823	NULL
to	NULL
-155	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
-113	NULL
and	NULL
-105	NULL
deletion	NULL
mutants	NULL
(	NULL
pGP	NULL
(	NULL
-113	NULL
)	NULL
CAT	NULL
and	NULL
pGP	NULL
(	NULL
-105	NULL
)	NULL
CAT	NULL
)	NULL
,	NULL
which	NULL
retained	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
.	NULL

The	NULL
-113	NULL
mutant	NULL
exhibited	NULL
CAT	NULL
activities	NULL
of	NULL
7.8	NULL
and	NULL
3.6	NULL
%	NULL
conversions	NULL
with	NULL
and	NULL
without	NULL
Tax	NULL
,	NULL
respectively	NULL
,	NULL
showing	NULL
2.2-fold	NULL
activation	NULL
.	NULL

Introduction	NULL
of	NULL
the	NULL
upstream	NULL
fragment	NULL
reduced	NULL
CAT	NULL
activities	NULL
to	NULL
2.4	NULL
and	NULL
0.26	NULL
%	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
Tax	NULL
,	NULL
respectively	NULL
,	NULL
resulting	NULL
in	NULL
8.8-fold	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
with	NULL
the	NULL
-105	NULL
mutant	NULL
construct	NULL
,	NULL
which	NULL
showed	NULL
an	NULL
increase	NULL
in	NULL
fold	NULL
activation	NULL
from	NULL
2.7	NULL
to	NULL
5.6	NULL
by	NULL
introduction	NULL
of	NULL
the	NULL
upstream	NULL
sequence	NULL
.	NULL

The	NULL
-31	NULL
mutant	NULL
,	NULL
carrying	NULL
only	NULL
the	NULL
core	NULL
promoter	NULL
,	NULL
showed	NULL
basal	NULL
promoter	NULL
activity	NULL
irrespective	NULL
of	NULL
Tax	NULL
;	NULL
however	NULL
,	NULL
addition	NULL
of	NULL
the	NULL
upstream	NULL
sequence	NULL
significantly	NULL
reduced	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
illustrated	NULL
that	NULL
the	NULL
upstream	NULL
sequence	NULL
,	NULL
which	NULL
lacks	NULL
Tax	NULL
responsiveness	NULL
can	NULL
suppress	NULL
basal	NULL
promoter	NULL
activity	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
upstream	NULL
fragment	NULL
reduced	NULL
CAT	NULL
activity	NULL
to	NULL
a	NULL
greater	NULL
extent	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Tax	NULL
than	NULL
in	NULL
its	NULL
presence	NULL
,	NULL
generating	NULL
a	NULL
higher	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
Tax	NULL
.	NULL

Alterna-tively	NULL
,	NULL
Tax	NULL
may	NULL
be	NULL
able	NULL
to	NULL
relieve	NULL
the	NULL
suppressive	NULL
effect	NULL
of	NULL
the	NULL
upstream	NULL
fragment	NULL
.	NULL

DISCUSSION	NULL
Initial	NULL
studies	NULL
of	NULL
gp34	NULL
demonstrated	NULL
that	NULL
its	NULL
expression	NULL
was	NULL
restricted	NULL
to	NULL
cells	NULL
expressing	NULL
HTLV-I	NULL
.	NULL

It	NULL
was	NULL
therefore	NULL
specu-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
14124	NULL
HTLV-I	NULL
Tax-mediated	NULL
Activation	NULL
of	NULL
the	NULL
gp34	NULL
Gene	NULL
Promoter	NULL
Fold	NULL
A	NULL
CAT	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
n	NULL
ecfrstion	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
-31	NULL
EMH	NULL
CAT	NULL
1.4	NULL
(	NULL
-100	NULL
--	NULL
54	NULL
)	NULL
me	NULL
-_	NULL
4.5	NULL
(	NULL
-100~-54	NULL
)	NULL
-	NULL
=	NULL
1.8	NULL
(	NULL
-100~-54	NULL
)	NULL
-	NULL
mee	NULL
-	NULL
[	NULL
__	NULL
1.8	NULL
(	NULL
-100~-54	NULL
)	NULL
eam	NULL
~~	NULL
1.6	NULL
(	NULL
-100~-54	NULL
)	NULL
x	NULL
4	NULL
94.0	NULL
(	NULL
-100~-54	NULL
)	NULL
R	NULL
x	NULL
3	NULL
-	NULL
(	NULL
-=	NULL
[	NULL
=~	NULL
<	NULL
=	NULL
<	NULL
r	NULL
[	NULL
_	NULL
5.8	NULL
[	NULL
I	NULL
NF-x8	NULL
like	NULL
1	NULL
.	NULL

(	NULL
RR	NULL
___	NULL
a	NULL
1	NULL
.	NULL

=x	NULL
[	NULL
=+	NULL
|=	NULL
>	NULL
B-	NULL
___	NULL
NF-xB	NULL
like	NULL
1	NULL
x	NULL
4	NULL
i	NULL
14.0	NULL
I	NULL
NF-xB	NULL
like	NULL
1	NULL
Mut	NULL
x	NULL
4	NULL
_	NULL
1.5	NULL
a	NULL
8	NULL
NF-x8	NULL
like	NULL
2	NULL
RM	NULL
___	NULL
&	NULL
1.0	NULL
a.	NULL
NF-xB	NULL
lik	NULL
g	NULL
F-xB	NULL
like	NULL
2	NULL
x	NULL
4	NULL
-	NULL
___	NULL
***	NULL
HH	NULL
+7	NULL
1.6	NULL
=	NULL
%	NULL
g	NULL
NF-xB	NULL
like	NULL
2	NULL
Mut	NULL
x	NULL
4	NULL
1.1	NULL
g	NULL
HTLV-I	NULL
Core	NULL
Prom	NULL
.	NULL

:	NULL
|	NULL
Uy	NULL
,	NULL
NF-x8	NULL
x	NULL
4	NULL
12.6	NULL
@	NULL
mp	NULL
___|	NULL
§	NULL
49	NULL
.	NULL

B	NULL
CAT	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
Fold	NULL
Activation	NULL
4	NULL
Tax	NULL
E	NULL
o	NULL
100	NULL
200	NULL
30	NULL
40	NULL
50	NULL
60	NULL
2	NULL
o	NULL
3	NULL
#	NULL
<	NULL
&	NULL
wT	NULL
38	NULL
5	NULL
+27	NULL
3	NULL
-823	NULL
CAT	NULL
.	NULL

M22	NULL
3.8	NULL
G	NULL
703	NULL
27	NULL
d3	NULL
35	NULL
wT	NULL
42	NULL
HTLV-I	NULL
Core	NULL
Prom	NULL
.	NULL

NF-	NULL
«	NULL
8x4	NULL
]	NULL
H	NULL
M22	NULL
1.5	NULL
703	NULL
42	NULL
d3	NULL
42	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
in	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
the	NULL
gp34	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
Tax-responsive	NULL
region	NULL
in	NULL
the	NULL
gp34	NULL
gene	NULL
regulatory	NULL
region	NULL
.	NULL

CAT	NULL
reporter	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
together	NULL
with	NULL
or	NULL
without	NULL
pMAXneo	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CdCl	NULL
,	NULL
for	NULL
36	NULL
h	NULL
and	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
was	NULL
determined	NULL
.	NULL

The	NULL
reporter	NULL
plasmids	NULL
carried	NULL
the	NULL
isolated	NULL
-100	NULL
to	NULL
-54	NULL
fragment	NULL
and	NULL
synthesized	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
in	NULL
single	NULL
and	NULL
tandem	NULL
repeat	NULL
forms	NULL
in	NULL
a	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
pGP	NULL
(	NULL
-31	NULL
)	NULL
CAT	NULL
with	NULL
the	NULL
gp34	NULL
core	NULL
promoter	NULL
.	NULL

Mutant	NULL
fragments	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
,	NULL
indicated	NULL
by	NULL
dotted	NULL
arrows	NULL
,	NULL
were	NULL
similarly	NULL
tested	NULL
.	NULL

CAT	NULL
activities	NULL
in	NULL
cells	NULL
with	NULL
and	NULL
without	NULL
pMAXneo	NULL
were	NULL
compared	NULL
.	NULL

B	NULL
,	NULL
responsiveness	NULL
of	NULL
the	NULL
gp34	NULL
promoter	NULL
to	NULL
Tax	NULL
mutants	NULL
.	NULL

pGP	NULL
(	NULL
-823	NULL
)	NULL
CAT	NULL
was	NULL
cotransfected	NULL
along	NULL
with	NULL
vectors	NULL
for	NULL
wild	NULL
type	NULL
Tax	NULL
(	NULL
pMT2Tax	NULL
)	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
Tax	NULL
mutants	NULL
TaxM22	NULL
,	NULL
Tax703	NULL
and	NULL
Taxd8	NULL
into	NULL
Jurkat	NULL
cells	NULL
,	NULL
and	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
was	NULL
determined	NULL
.	NULL

pHBAPr-l-neo	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

HTLV-I	NULL
Tax-mediated	NULL
Activation	NULL
of	NULL
the	NULL
gp34	NULL
Gene	NULL
Promoter	NULL
TaBLE	NULL
I	NULL
Nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
Ref	NULL
.	NULL

gp34	NULL
NF-	NULL
«	NULL
B-like	NULL
1	NULL
GGGGAAATTCA	NULL
gp34	NULL
NF-	NULL
«	NULL
B-like	NULL
2	NULL
GGGGAACTTCT	NULL
HTLV-I	NULL
C26	NULL
GGTGGcTTCCcC	NULL
60	NULL
Immunoglobulin	NULL
GGGGACTTTCC	NULL
64	NULL
SV40	NULL
GGGGACcTTTCC	NULL
56	NULL
HIV*	NULL
GGGGACcTTTCC	NULL
65	NULL
HIV	NULL
AGGGACTTTCC	NULL
65	NULL
*	NULL
HIV	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

lated	NULL
that	NULL
gp34	NULL
was	NULL
a	NULL
product	NULL
of	NULL
HTLV-I	NULL
,	NULL
because	NULL
treatment	NULL
with	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
,	NULL
which	NULL
is	NULL
thought	NULL
to	NULL
mimic	NULL
antigen-dependent	NULL
stimulation	NULL
,	NULL
was	NULL
not	NULL
effective	NULL
in	NULL
inducing	NULL
gp34	NULL
expression	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
T	NULL
cell	NULL
lines	NULL
(	NULL
35	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
previously	NULL
demonstrated	NULL
that	NULL
gp34	NULL
is	NULL
encoded	NULL
by	NULL
a	NULL
cellular	NULL
gene	NULL
that	NULL
is	NULL
a	NULL
target	NULL
of	NULL
the	NULL
transcriptional	NULL
transactivation	NULL
function	NULL
of	NULL
HTLV-I	NULL
Tax	NULL
(	NULL
86	NULL
)	NULL
.	NULL

Tax	NULL
activates	NULL
several	NULL
cellular	NULL
genes	NULL
,	NULL
most	NULL
of	NULL
which	NULL
are	NULL
involved	NULL
in	NULL
cellular	NULL
signals	NULL
for	NULL
growth	NULL
.	NULL

gp34	NULL
differs	NULL
from	NULL
other	NULL
cellular	NULL
genes	NULL
transactivated	NULL
by	NULL
Tax	NULL
in	NULL
that	NULL
other	NULL
Tax-responsive	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
the	NULL
gene	NULL
for	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
,	NULL
the	NULL
gene	NULL
for	NULL
IL-6	NULL
,	NULL
c-fos	NULL
,	NULL
and	NULL
c-jun	NULL
,	NULL
are	NULL
induced	NULL
by	NULL
mitogens	NULL
,	NULL
phorbol	NULL
ester	NULL
,	NULL
ionophores	NULL
,	NULL
and	NULL
IL-2	NULL
,	NULL
whereas	NULL
gp34	NULL
is	NULL
not	NULL
.	NULL

gp34	NULL
is	NULL
expressed	NULL
on	NULL
normal	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
activated	NULL
by	NULL
antigen	NULL
stimulation	NULL
and	NULL
physically	NULL
associates	NULL
with	NULL
OX40	NULL
(	NULL
38-40	NULL
and	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

OX40	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
transcriptionally	NULL
activated	NULL
by	NULL
Tax	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
gp34	NULL
and	NULL
OX40	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
transduce	NULL
intracytoplasmic	NULL
signals	NULL
upon	NULL
association	NULL
(	NULL
38-40	NULL
)	NULL
,	NULL
implying	NULL
that	NULL
the	NULL
gp34/OX40	NULL
system	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
growth	NULL
of	NULL
normal	NULL
and	NULL
malignant	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
gp34	NULL
gene	NULL
promoter	NULL
region	NULL
that	NULL
is	NULL
transactivated	NULL
by	NULL
Tax	NULL
.	NULL

Our	NULL
data	NULL
provide	NULL
important	NULL
features	NULL
of	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
mechanism	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
.	NULL

First	NULL
,	NULL
transactivation	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
by	NULL
Tax	NULL
is	NULL
mediated	NULL
through	NULL
a	NULL
46-bp	NULL
sequence	NULL
carrying	NULL
two	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
.	NULL

An	NULL
increase	NULL
in	NULL
binding	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
members	NULL
to	NULL
the	NULL
elements	NULL
could	NULL
be	NULL
a	NULL
mechanism	NULL
for	NULL
transactivation	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
upstream	NULL
region	NULL
can	NULL
suppress	NULL
promoter-driven	NULL
basic	NULL
transcription	NULL
.	NULL

Two	NULL
distinct	NULL
NF-	NULL
«	NULL
B-like	NULL
sequences	NULL
exist	NULL
in	NULL
the	NULL
Tax-responsive	NULL
region	NULL
of	NULL
gp34	NULL
.	NULL

Both	NULL
sequences	NULL
bound	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
members	NULL
in	NULL
Tax-expressing	NULL
cell	NULL
extracts	NULL
in	NULL
vitro	NULL
;	NULL
however	NULL
,	NULL
two	NULL
elements	NULL
seemed	NULL
to	NULL
be	NULL
different	NULL
in	NULL
binding	NULL
affinity	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
members	NULL
:	NULL
element	NULL
1	NULL
showed	NULL
higher	NULL
affinity	NULL
than	NULL
element	NULL
2	NULL
.	NULL

This	NULL
may	NULL
be	NULL
one	NULL
reason	NULL
that	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
alone	NULL
,	NULL
when	NULL
repeated	NULL
,	NULL
is	NULL
sufficient	NULL
for	NULL
conferring	NULL
Tax	NULL
responsiveness	NULL
,	NULL
whereas	NULL
no	NULL
Tax-induced	NULL
activation	NULL
was	NULL
seen	NULL
with	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
2	NULL
,	NULL
even	NULL
with	NULL
the	NULL
tandemly	NULL
repeated	NULL
form	NULL
.	NULL

It	NULL
is	NULL
thus	NULL
obvious	NULL
that	NULL
there	NULL
is	NULL
a	NULL
functional	NULL
difference	NULL
between	NULL
NF-B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
.	NULL

NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
behaves	NULL
much	NULL
like	NULL
typical	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
transactivated	NULL
by	NULL
Tax	NULL
via	NULL
increased	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
27	NULL
,	NULL
56	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
differs	NULL
in	NULL
sequence	NULL
by	NULL
three	NULL
bases	NULL
from	NULL
the	NULL
SV40	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
.	NULL

NF-	NULL
«	NULL
B-like	NULL
element	NULL
2	NULL
also	NULL
has	NULL
three	NULL
base	NULL
substitutions	NULL
from	NULL
the	NULL
SV40	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
,	NULL
which	NULL
are	NULL
also	NULL
distinct	NULL
from	NULL
those	NULL
in	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
l-mediated	NULL
response	NULL
to	NULL
Tax	NULL
in	NULL
a	NULL
tandemly	NULL
repeated	NULL
form	NULL
was	NULL
much	NULL
lower	NULL
than	NULL
the	NULL
native	NULL
-100	NULL
to	NULL
-54	NULL
fragment	NULL
,	NULL
which	NULL
carries	NULL
one	NULL
copy	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
.	NULL

The	NULL
three	NULL
base	NULL
substitutions	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
element	NULL
1	NULL
may	NULL
reduce	NULL
binding	NULL
affinity	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
members	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
weaker	NULL
response	NULL
to	NULL
Tax	NULL
than	NULL
the	NULL
typical	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
a	NULL
possible	NULL
participation	NULL
14125	NULL
of	NULL
another	NULL
element	NULL
(	NULL
s	NULL
)	NULL
in	NULL
Tax-induced	NULL
gp34	NULL
activation	NULL
.	NULL

Coexistence	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
in	NULL
the	NULL
-100	NULL
to	NULL
-54	NULL
fragment	NULL
may	NULL
stabilize	NULL
the	NULL
association	NULL
between	NULL
the	NULL
factors	NULL
and	NULL
DNA	NULL
elements	NULL
,	NULL
presumably	NULL
efficiently	NULL
,	NULL
to	NULL
render	NULL
the	NULL
complex	NULL
active	NULL
.	NULL

A	NULL
particular	NULL
configuration	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
binding	NULL
sites	NULL
may	NULL
be	NULL
required	NULL
for	NULL
active	NULL
transcription	NULL
.	NULL

The	NULL
location	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
,	NULL
with	NULL
a	NULL
space	NULL
between	NULL
them	NULL
,	NULL
may	NULL
be	NULL
adequate	NULL
for	NULL
formation	NULL
of	NULL
complexes	NULL
of	NULL
binding	NULL
factors	NULL
and	NULL
DNA	NULL
elements	NULL
.	NULL

NF-	NULL
«	NULL
B-like	NULL
element	NULL
2	NULL
is	NULL
reminiscent	NULL
of	NULL
another	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
,	NULL
the	NULL
C26	NULL
element	NULL
in	NULL
the	NULL
HTLV-I	NULL
enhancer	NULL
(	NULL
60	NULL
)	NULL
.	NULL

This	NULL
element	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
but	NULL
does	NULL
not	NULL
activate	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
Tax	NULL
by	NULL
itself	NULL
,	NULL
even	NULL
in	NULL
tandem	NULL
repeat	NULL
form	NULL
,	NULL
whereas	NULL
it	NULL
can	NULL
cooperate	NULL
with	NULL
Tax	NULL
to	NULL
augment	NULL
transactivation	NULL
of	NULL
the	NULL
21-bp	NULL
motif	NULL
in	NULL
the	NULL
HTLV-I	NULL
enhancer	NULL
.	NULL

The	NULL
C26	NULL
element	NULL
also	NULL
differs	NULL
by	NULL
three	NULL
bases	NULL
from	NULL
the	NULL
typical	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
,	NULL
and	NULL
it	NULL
competed	NULL
partially	NULL
in	NULL
complex	NULL
formation	NULL
with	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Apart	NULL
from	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
,	NULL
there	NULL
may	NULL
be	NULL
other	NULL
elements	NULL
in	NULL
the	NULL
-100	NULL
to	NULL
-54	NULL
fragment	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
activation	NULL
by	NULL
Tax	NULL
.	NULL

An	NULL
AP-1	NULL
site-like	NULL
sequence	NULL
between	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
1	NULL
and	NULL
2	NULL
may	NULL
be	NULL
effective	NULL
in	NULL
formation	NULL
of	NULL
more	NULL
stable	NULL
configuration	NULL
of	NULL
the	NULL
factor/DNA	NULL
element	NULL
complex	NULL
.	NULL

This	NULL
may	NULL
involve	NULL
a	NULL
factor	NULL
bound	NULL
to	NULL
the	NULL
AP-1	NULL
site-like	NULL
element	NULL
.	NULL

This	NULL
notion	NULL
is	NULL
supported	NULL
by	NULL
recent	NULL
observations	NULL
of	NULL
functional	NULL
interactions	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
other	NULL
cellular	NULL
transcription	NULL
factors	NULL
,	NULL
for	NULL
example	NULL
,	NULL
C/EBP	NULL
,	NULL
the	NULL
ATF	NULL
family	NULL
,	NULL
and	NULL
Jun/Fos	NULL
(	NULL
61-63	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B-like	NULL
element	NULL
2	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
and	NULL
the	NULL
C26	NULL
element	NULL
in	NULL
the	NULL
HTLV-I	NULL
enhancer	NULL
may	NULL
constitute	NULL
a	NULL
new	NULL
subfamily	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
,	NULL
which	NULL
can	NULL
not	NULL
activate	NULL
transcription	NULL
despite	NULL
being	NULL
able	NULL
to	NULL
bind	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
augment	NULL
transcription	NULL
by	NULL
cooperation	NULL
with	NULL
other	NULL
enhancers	NULL
.	NULL

Many	NULL
transcriptional	NULL
regulatory	NULL
regions	NULL
containing	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
are	NULL
activated	NULL
by	NULL
TPA	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
are	NULL
unique	NULL
in	NULL
that	NULL
they	NULL
are	NULL
not	NULL
activated	NULL
by	NULL
TPA	NULL
treatment	NULL
,	NULL
even	NULL
though	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
elements	NULL
was	NULL
induced	NULL
by	NULL
treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
TPA	NULL
.	NULL

This	NULL
presumably	NULL
accounts	NULL
for	NULL
the	NULL
unresponsiveness	NULL
of	NULL
the	NULL
native	NULL
gp34	NULL
promoter	NULL
to	NULL
TPA	NULL
and	NULL
further	NULL
suggests	NULL
unresponsiveness	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
to	NULL
PHA	NULL
.	NULL

Stimulation	NULL
with	NULL
PHA	NULL
is	NULL
generally	NULL
accepted	NULL
to	NULL
mimic	NULL
antigen	NULL
stimulation	NULL
.	NULL

Indeed	NULL
,	NULL
parameters	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
production	NULL
,	NULL
nuclear	NULL
oncogene	NULL
expression	NULL
,	NULL
and	NULL
cell	NULL
proliferation	NULL
,	NULL
are	NULL
indistinguishable	NULL
between	NULL
antigen	NULL
and	NULL
PHA	NULL
stimulation	NULL
.	NULL

However	NULL
,	NULL
gp34	NULL
differs	NULL
in	NULL
that	NULL
its	NULL
expression	NULL
is	NULL
not	NULL
induced	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
and	NULL
T	NULL
cell	NULL
lines	NULL
by	NULL
PHA	NULL
stimulation	NULL
.	NULL

We	NULL
found	NULL
transcriptionally	NULL
suppressive	NULL
activity	NULL
associated	NULL
with	NULL
the	NULL
upstream	NULL
region	NULL
.	NULL

This	NULL
region	NULL
alone	NULL
profoundly	NULL
prevented	NULL
basic	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
suppression	NULL
was	NULL
independent	NULL
of	NULL
the	NULL
core	NULL
promoter	NULL
.	NULL

Tax	NULL
appeared	NULL
not	NULL
to	NULL
affect	NULL
the	NULL
suppressive	NULL
region	NULL
by	NULL
itself	NULL
.	NULL

The	NULL
strictly	NULL
regulated	NULL
gp34	NULL
expression	NULL
may	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
suppressive	NULL
activity	NULL
of	NULL
the	NULL
upstream	NULL
region	NULL
.	NULL

Exactly	NULL
how	NULL
the	NULL
upstream	NULL
sequence	NULL
suppresses	NULL
transcription	NULL
is	NULL
presently	NULL
unknown	NULL
.	NULL

Further	NULL
experiments	NULL
are	NULL
required	NULL
to	NULL
precisely	NULL
identify	NULL
the	NULL
suppressive	NULL
region	NULL
and	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
associated	NULL
with	NULL
such	NULL
a	NULL
region	NULL
.	NULL

Kinetics	NULL
of	NULL
Tax-induced	NULL
gp34	NULL
expression	NULL
were	NULL
far	NULL
slower	NULL
than	NULL
those	NULL
of	NULL
other	NULL
genes	NULL
induced	NULL
by	NULL
Tax	NULL
(	NULL
86	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
intrinsic	NULL
gp34	NULL
promoter	NULL
has	NULL
weak	NULL
activity	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Sequences	NULL
upstream	NULL
of	NULL
-823	NULL
may	NULL
contain	NULL
some	NULL
other	NULL
suppressive	NULL
activity	NULL
because	NULL
the	NULL
-9000	NULL
fragment	NULL
exhibited	NULL
lower	NULL
promoter	NULL
activity	NULL
than	NULL
the	NULL
-2700	NULL
and	NULL
-823	NULL
fragments	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
preliminary	NULL
Northern	NULL
blot	NULL
demonstrated	NULL
that	NULL
the	NULL
half-life	NULL
of	NULL
gp34	NULL
mRNA	NULL
was	NULL
quite	NULL
long	NULL
(	NULL
12-24	NULL
h	NULL
)	NULL
.	NULL
``	NULL

Taken	NULL
together	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
gp34	NULL
2	NULL
K.	NULL
Ohtani	NULL
and	NULL
M.	NULL
Nakamura	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
HTLV-I	NULL
Tax-mediated	NULL
Activation	NULL
of	NULL
the	NULL
gp34	NULL
Gene	NULL
Promoter	NULL
14126	NULL
TL-Mor	NULL
Extract	NULL
Extract	NULL
E	NULL
¢	NULL
Oui	NULL
Bx-4N	NULL
5	NULL
3	NULL
TL-Mor	NULL
F	NULL
iz	NULL
uH	NULL
970	NULL
FATLH	NULL
@	NULL
-aN	NULL
ini	NULL
£	NULL
9411	NULL
@	NULL
-1	NULL
9x11	NULL
@	NULL
x-4N	NULL
in	NULL
2	NULL
oll	NULL
z	NULL
sull	NULL
@	NULL
-a4Nn	NULL
Competitor	NULL
E	NULL
7	NULL
!	NULL

£	NULL
#	NULL
11	NULL
12	NULL
FPMLH	NULL
979	NULL
FTLH	NULL
@	NULL
rean	NULL
.|	NULL
.	NULL

10W	NULL
2	NULL
941	NULL
@	NULL
+-4N	NULL
m	NULL
2	NULL
oxi	NULL
@	NULL
-4N	NULL
2	NULL
WNW	NULL
1	NULL
OH	NULL
!	NULL
]	NULL

L	NULL
9M	NULL
Extract	NULL
Competitor	NULL
12	NULL
FAMTLH	NULL
929	NULL
FATLH	NULL
ini	NULL
2	NULL
0x1	NULL
]	NULL
g*-4N	NULL
coun	NULL
gx	NULL
--	NULL
n	NULL
$	NULL
nw	NULL
Lown	NULL
gx-3Nn	NULL
fp	NULL
Lox	NULL
!	NULL

gx-4N	NULL
#	NULL
(	NULL
rs-~o01-	NULL
)	NULL
|	NULL
Competitor	NULL
Downloaded	NULL
from	NULL
http	NULL
:	NULL
//www	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
11	NULL
12	NULL
2	NULL
8	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1	NULL
§	NULL
6	NULL
7	NULL
80	NULL
9	NULL
10	NULL
1112	NULL
2	NULL
3	NULL
4	NULL
Element	NULL
2	NULL
Element	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
1	NULL
TL-Mor	NULL
Extract	NULL
Element	NULL
2	NULL
Element	NULL
1	NULL
Competitor	NULL
JON	NULL
TL	NULL
10W	NULL
(	NULL
+	NULL
)	NULL
6-XaP	NULL
(	NULL
+	NULL
)	NULL
6-XaP	NULL
(	NULL
-	NULL
)	NULL
6-xar	NULL
JOW	NULL
TL	NULL
JOW-T.	NULL
(	NULL
+	NULL
)	NULL
6-XdP	NULL
(	NULL
+	NULL
)	NULL
6-XaP	NULL
{	NULL
-	NULL
)	NULL
6-xar	NULL
Extract	NULL
Competitor	NULL
Typical	NULL
NF-kB	NULL
Element	NULL
2	NULL
€	NULL
©	NULL
E	NULL
®	NULL
w	NULL
asd	NULL
1	NULL
gick	NULL
P	NULL
ley-o	NULL
®	NULL
osd	NULL
R	NULL
g9d	NULL
I	NULL
-	NULL
1	NULL
2gd	NULL
8	NULL
194	NULL
|	NULL
ogd	NULL
*	NULL
god	NULL
oquo9	NULL
asd	NULL
!	NULL

g	NULL
lod	NULL
(	NULL
ley-o	NULL
4	NULL
Antibodies	NULL
l	NULL
<	NULL
<	NULL
--	NULL
.	NULL

b	NULL
-	NULL
»	NULL
Element	NULL
2	NULL
Typical	NULL
NF-xB	NULL
Element	NULL
1	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

HTLV-I	NULL
Tax-mediated	NULL
Activation	NULL
of	NULL
the	NULL
gp34	NULL
Gene	NULL
Promoter	NULL
14127	NULL
yx	NULL
Fold	NULL
CAT	NULL
Activity	NULL
(	NULL
%	NULL
A	NULL
£86	NULL
)	NULL
Activation	NULL
20	NULL
40	NULL
+27	NULL
s23	NULL
&	NULL
am	NULL
|	NULL
CAs	NULL
0.9	NULL
[	NULL
]	NULL
-tra	NULL
-31	NULL
He-	NULL
___	NULL
1.1	NULL
|	NULL
n	NULL
(	NULL
-100~-54	NULL
)	NULL
-	NULL
(	NULL
=	NULL
>	NULL
-I-	NULL
___	NULL
1	NULL
.	NULL

NF-	NULL
B	NULL
like	NULL
1	NULL
x	NULL
4	NULL
_	NULL
[	NULL
wt	NULL
[	NULL
mate	NULL
[	NULL
mad	NULL
[	NULL
mt	NULL
|	NULL
0.6	NULL
NF-xB	NULL
like	NULL
2	NULL
x	NULL
4	NULL
|	NULL
1.0	NULL
HTLV-I	NULL
Core	NULL
Prom	NULL
.	NULL

___	NULL
Copppopaf	NULL
_C	NULL
~*~	NULL
5.0	NULL
|	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Element	NULL
1	NULL
Element	NULL
2	NULL
|	NULL
1	NULL
1	NULL
EE	NULL
.	NULL

ff	NULL
Extract	NULL
-P	NULL
p	NULL
5	NULL
5	NULL
q	NULL
Fl	NULL
3	NULL
3	NULL
Competitor	NULL
ooc	NULL
JV	NULL
.	NULL

Fic	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
TPA	NULL
on	NULL
the	NULL
gp34	NULL
gene	NULL
regulatory	NULL
region	NULL
.	NULL

A	NULL
,	NULL
no	NULL
activation	NULL
of	NULL
gp34	NULL
promoter	NULL
by	NULL
TPA	NULL
.	NULL

CAT	NULL
reporter	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
with	NULL
20	NULL
nM	NULL
TPA	NULL
for	NULL
36	NULL
h	NULL
,	NULL
and	NULL
CAT	NULL
activities	NULL
were	NULL
compared	NULL
between	NULL
TPA-treated	NULL
and	NULL
untreated	NULL
cells	NULL
.	NULL

B	NULL
,	NULL
TPA-induced	NULL
complex	NULL
formation	NULL
of	NULL
Jurkat	NULL
extract	NULL
with	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
.	NULL

NF-xB-like	NULL
element	NULL
1	NULL
or	NULL
2	NULL
was	NULL
mixed	NULL
with	NULL
extracts	NULL
from	NULL
TL-Mor	NULL
and	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
20	NULL
nM	NULL
TPA	NULL
for	NULL
7	NULL
h.	NULL
Specific	NULL
binding	NULL
with	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
TL-Mor	NULL
extract	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

Fig	NULL
.	NULL

4.Tax-dependent	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
to	NULL
the	NULL
Tax-responsive	NULL
elements	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
complex	NULL
formation	NULL
between	NULL
the	NULL
Tax-responsive	NULL
element	NULL
and	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
TL-Mor	NULL
(	NULL
Zanes	NULL
2-10	NULL
)	NULL
and	NULL
Jurkat	NULL
(	NULL
Zanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
the	NULL
-100	NULL
to	NULL
-54	NULL
fragment	NULL
(	NULL
A	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
,	NULL
or	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
2	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
no	NULL
nuclear	NULL
extract	NULL
.	NULL

The	NULL
protein-DNA	NULL
fragment	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
4	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Competitors	NULL
used	NULL
were	NULL
the	NULL
-100	NULL
to	NULL
-54	NULL
fragment	NULL
,	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
,	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
mutant	NULL
,	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
2	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
2	NULL
mutant	NULL
.	NULL

The	NULL
C26	NULL
element	NULL
and	NULL
21-bp	NULL
motif	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
HTLV-I	NULL
were	NULL
also	NULL
used	NULL
as	NULL
competitors	NULL
.	NULL

Competitor	NULL
fragments	NULL
were	NULL
added	NULL
at	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
.	NULL

Specific	NULL
bands	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

C	NULL
,	NULL
Tax-dependent	NULL
binding	NULL
activity	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
JPX-9	NULL
cells	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
CdCl	NULL
,	NULL
(	NULL
20	NULL
nm	NULL
CdCl	NULL
,	NULL
for	NULL
24	NULL
h	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
or	NULL
2	NULL
.	NULL

The	NULL
same	NULL
element	NULL
was	NULL
used	NULL
as	NULL
a	NULL
competitor	NULL
for	NULL
each	NULL
probe	NULL
.	NULL

The	NULL
band	NULL
with	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
that	NULL
with	NULL
TL-Mor	NULL
extract	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

D	NULL
,	NULL
the	NULL
same	NULL
mobility	NULL
of	NULL
complexes	NULL
with	NULL
NF-	NULL
«	NULL
B-like	NULL
elements	NULL
as	NULL
with	NULL
typical	NULL
NF-KB	NULL
site	NULL
.	NULL

TL-Mor	NULL
extract	NULL
was	NULL
mixed	NULL
either	NULL
with	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
1	NULL
or	NULL
2	NULL
or	NULL
with	NULL
a	NULL
typical	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
same	NULL
element	NULL
was	NULL
used	NULL
as	NULL
a	NULL
competitor	NULL
for	NULL
each	NULL
probe	NULL
.	NULL

The	NULL
band	NULL
with	NULL
the	NULL
same	NULL
mobility	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

E	NULL
,	NULL
gel	NULL
mobility	NULL
supershift	NULL
assay	NULL
with	NULL
antibodies	NULL
against	NULL
NF-B	NULL
family	NULL
members	NULL
.	NULL

Gel	NULL
shift	NULL
assay	NULL
reaction	NULL
mixtures	NULL
containing	NULL
TL-Mor	NULL
extract	NULL
and	NULL
indicated	NULL
antibodies	NULL
were	NULL
incubated	NULL
for	NULL
3	NULL
h	NULL
,	NULL
and	NULL
then	NULL
a	NULL
probe	NULL
,	NULL
NF-xB-like	NULL
element	NULL
1	NULL
or	NULL
2	NULL
,	NULL
or	NULL
a	NULL
typical	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
was	NULL
added	NULL
.	NULL

Supershifted	NULL
bands	NULL
with	NULL
anti-NF-xB	NULL
p65	NULL
,	NULL
anti-NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
and	NULL
anti-RelB	NULL
antibodies	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
with	NULL
a	NULL
,	NULL
b	NULL
,	NULL
and	NULL
c	NULL
,	NULL
respectively	NULL
.	NULL

14128	NULL
HTLV-I	NULL
Tax-mediated	NULL
Activation	NULL
of	NULL
the	NULL
gp34	NULL
Gene	NULL
Promoter	NULL
mas	NULL
Fold	NULL
CAT	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
Activation	NULL
oe	NULL
b	NULL
0	NULL
pug	NULL
s27	NULL
___	NULL
]	NULL
413	NULL
C	NULL
--	NULL
--	NULL
H	NULL
car	NULL
2.2	NULL
p	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Suppressive	NULL
effects	NULL
of	NULL
the	NULL
154	NULL
|	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
823	NULL
{	NULL
___	NULL
m	NULL
8.3	NULL
regulatory	NULL
region	NULL
.	NULL

The	NULL
upstream	NULL
fragment	NULL
(	NULL
-828	NULL
to	NULL
-154	NULL
)	NULL
was	NULL
inserted	NULL
into	NULL
j	NULL
pGP	NULL
(	NULL
-113	NULL
)	NULL
CAT	NULL
,	NULL
pGP	NULL
(	NULL
-105	NULL
)	NULL
CAT	NULL
,	NULL
and	NULL
105	NULL
C	NULL
--	NULL
--	NULL
H	NULL
2.7	NULL
pGP	NULL
(	NULL
-31	NULL
)	NULL
CAT	NULL
.	NULL

These	NULL
plasmids	NULL
were	NULL
_	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
with	NULL
and	NULL
without	NULL
pMAXneo	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
``	NULL
154	NULL
with	NULL
CdCl	NULL
,	NULL
for	NULL
36	NULL
h	NULL
,	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
823	NULL
e	NULL
|7	NULL
5.6	NULL
measured	NULL
.	NULL

m	NULL
[	NULL
]	NULL
-tax	NULL
31	NULL
CH	NULL
1.1	NULL
-	NULL
+	NULL
Tax	NULL
-154	NULL
+2	NULL
.	NULL

-	NULL
-	NULL
(	NULL
___	NULL
1.5	NULL
mRNA	NULL
requires	NULL
a	NULL
couple	NULL
of	NULL
days	NULL
to	NULL
accumulate	NULL
to	NULL
a	NULL
sufficient	NULL
level	NULL
for	NULL
detection	NULL
by	NULL
Northern	NULL
blotting	NULL
,	NULL
and	NULL
thereafter	NULL
,	NULL
expression	NULL
is	NULL
maintained	NULL
at	NULL
that	NULL
level	NULL
for	NULL
a	NULL
certain	NULL
period	NULL
.	NULL

This	NULL
may	NULL
reflect	NULL
the	NULL
function	NULL
of	NULL
gp34	NULL
,	NULL
although	NULL
the	NULL
essential	NULL
role	NULL
of	NULL
the	NULL
gp34/0X40	NULL
system	NULL
remains	NULL
obscure	NULL
.	NULL

gp34	NULL
is	NULL
induced	NULL
during	NULL
immune	NULL
activation	NULL
,	NULL
and	NULL
the	NULL
inducible	NULL
mechanism	NULL
of	NULL
the	NULL
gp34	NULL
gene	NULL
is	NULL
strictly	NULL
controlled	NULL
.	NULL

OX40	NULL
is	NULL
also	NULL
inducible	NULL
,	NULL
unlike	NULL
other	NULL
members	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
family	NULL
(	NULL
FAS	NULL
,	NULL
TNF	NULL
receptor	NULL
,	NULL
and	NULL
CD40	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
production	NULL
of	NULL
gp34	NULL
may	NULL
be	NULL
important	NULL
in	NULL
either	NULL
maintaining	NULL
or	NULL
terminating	NULL
immune	NULL
reactions	NULL
.	NULL

Acknowledgments-We	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
T.	NULL
Kanno	NULL
for	NULL
helpful	NULL
dis-cussion	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
.	NULL

M.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Akagi	NULL
,	NULL
and	NULL
W.	NULL
Green	NULL
for	NULL
providing	NULL
Tax	NULL
mutant	NULL
plasmids	NULL
;	NULL
Y.	NULL
Matsumura	NULL
for	NULL
technical	NULL
assistance	NULL
;	NULL
and	NULL
H.	NULL
Shimizu	NULL
for	NULL
assistance	NULL
in	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Hinuma	NULL
,	NULL
Y.	NULL
,	NULL
Nagata	NULL
,	NULL
K.	NULL
,	NULL
Hanaoka	NULL
,	NULL
M.	NULL
,	NULL
Nakai	NULL
,	NULL
M.	NULL
,	NULL
Matsumoto	NULL
,	NULL
T.	NULL
,	NULL
Kinoshita	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Shirakawa	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Miyoshi	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

78	NULL
,	NULL
6476-6480	NULL
2	NULL
.	NULL

Poiesz	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Ruscetti	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Gazdar	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Bunn	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Minna	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1980	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

77	NULL
,	NULL
7415-7419	NULL
3	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Miyoshi	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

79	NULL
,	NULL
2031-2035	NULL
4	NULL
.	NULL

Gessain	NULL
,	NULL
A.	NULL
,	NULL
Barin	NULL
,	NULL
F.	NULL
,	NULL
Vernant	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Gout	NULL
,	NULL
O.	NULL
,	NULL
Maurs	NULL
,	NULL
L.	NULL
,	NULL
Calender	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
de	NULL
The	NULL
,	NULL
G.	NULL
(	NULL
1985	NULL
)	NULL
Lancet	NULL
2	NULL
,	NULL
407	NULL
5	NULL
.	NULL

Osame	NULL
,	NULL
M.	NULL
,	NULL
Igata	NULL
,	NULL
A.	NULL
,	NULL
Usuku	NULL
,	NULL
K.	NULL
,	NULL
Rosales	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Matsumoto	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Lancet	NULL
1	NULL
,	NULL
1031	NULL
.	NULL

Nagashima	NULL
,	NULL
K.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Seiki	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

60	NULL
,	NULL
894-399	NULL
.	NULL

Felber	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Paskaris	NULL
,	NULL
H.	NULL
,	NULL
Kleinman-Ewing	NULL
,	NULL
C.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Pavlakis	NULL
,	NULL
G.	NULL
N.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
229	NULL
,	NULL
675-679	NULL
8	NULL
.	NULL

Sedroski	NULL
,	NULL
J.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
,	NULL
Goh	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
and	NULL
Haseltine	NULL
,	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
228	NULL
,	NULL
1430-1484	NULL
9	NULL
.	NULL

Seiki	NULL
,	NULL
M.	NULL
,	NULL
Inoue	NULL
,	NULL
J.	NULL
,	NULL
Takeda	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

5	NULL
,	NULL
561-565	NULL
10	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
,	NULL
Poteat	NULL
,	NULL
H.	NULL
,	NULL
Tan	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Roeder	NULL
,	NULL
R.	NULL
,	NULL
Haseltine	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
89-92	NULL
11	NULL
.	NULL

Li	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Siekevitz	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
6490-6500	NULL
12	NULL
.	NULL

McGuire	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Curtiss	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
Larson	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

67	NULL
,	NULL
1590-1599	NULL
13	NULL
.	NULL

Himes	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Coles	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Katsikeros	NULL
,	NULL
R.	NULL
,	NULL
Lang	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
and	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
3189-3197	NULL
14	NULL
.	NULL

Nimer	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

8	NULL
,	NULL
997-1004	NULL
15	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Taniguchi	NULL
,	NULL
T.	NULL
,	NULL
Tsuru	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

5	NULL
,	NULL
2883-2888	NULL
16	NULL
.	NULL

Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Shibuya	NULL
,	NULL
H.	NULL
,	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Hatakeyama	NULL
,	NULL
M.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Inoue	NULL
,	NULL
J.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
848-350	NULL
17	NULL
.	NULL

Ohbo	NULL
,	NULL
K.	NULL
,	NULL
Takasawa	NULL
,	NULL
N.	NULL
,	NULL
Ishii	NULL
,	NULL
N.	NULL
,	NULL
Tanaka	NULL
,	NULL
N.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
7479-7486	NULL
18	NULL
.	NULL

Uchiumi	NULL
,	NULL
F.	NULL
,	NULL
Semba	NULL
,	NULL
K.	NULL
,	NULL
Yamanashi	NULL
,	NULL
Y.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Inoue	NULL
,	NULL
K.	NULL
,	NULL
Toyoshima	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
3784-3795	NULL
19	NULL
.	NULL

Fujii	NULL
,	NULL
M.	NULL
,	NULL
Sassone	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
8526-8530	NULL
20	NULL
.	NULL

Nagata	NULL
,	NULL
K.	NULL
,	NULL
Ohtani	NULL
,	NULL
K.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

63	NULL
,	NULL
3220-3226	NULL
21	NULL
.	NULL

Fujii	NULL
,	NULL
M.	NULL
,	NULL
Niki	NULL
,	NULL
T.	NULL
,	NULL
Mori	NULL
,	NULL
T.	NULL
,	NULL
Matsuda	NULL
,	NULL
T.	NULL
,	NULL
Matsui	NULL
,	NULL
M.	NULL
,	NULL
Nomura	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Seiki	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
1023-1029	NULL
22	NULL
.	NULL

Jeang	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
Shank	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
Kumar	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
8291-8295	NULL
28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43.	NULL
.	NULL

Gruss	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
Dower	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
85	NULL
,	NULL
3878-3404	NULL
45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Niki	NULL
,	NULL
M.	NULL
,	NULL
Ohtani	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
5207-5221	NULL
Poteat	NULL
,	NULL
H.	NULL
T.	NULL
,	NULL
Chen	NULL
,	NULL
F.	NULL
Y.	NULL
,	NULL
Kadison	NULL
,	NULL
P.	NULL
,	NULL
Sodroski	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
1264-1270	NULL
Tan	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
Horikoshi	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
1733-1745	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Wano	NULL
,	NULL
Y.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
1652-1655	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Sickevitz	NULL
,	NULL
M.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
827-836	NULL
Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
888	NULL
,	NULL
776-778	NULL
Fujii	NULL
,	NULL
M.	NULL
,	NULL
Tsuchiya	NULL
,	NULL
H.	NULL
,	NULL
Chubjo	NULL
,	NULL
T.	NULL
,	NULL
Akizawa	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Seiki	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
2066-2076	NULL
Zhao	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Giam	NULL
,	NULL
C.	NULL
Z	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
7070-7074	NULL
Suzuki	NULL
,	NULL
T.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Toita	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
610-614	NULL
Suzuki	NULL
,	NULL
T.	NULL
,	NULL
Hirai	NULL
,	NULL
H.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
2391-2397	NULL
Hirai	NULL
,	NULL
H.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J.	NULL
,	NULL
Suzuki	NULL
,	NULL
T.	NULL
,	NULL
Ueda	NULL
,	NULL
K.	NULL
,	NULL
Muramatsu	NULL
,	NULL
M.	NULL
,	NULL
Tsuboi	NULL
,	NULL
A.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Oncogene	NULL
7	NULL
,	NULL
1737-1742	NULL
Watanabe	NULL
,	NULL
M.	NULL
,	NULL
Muramatsu	NULL
,	NULL
M.	NULL
,	NULL
Hirai	NULL
,	NULL
H.	NULL
,	NULL
Suzuki	NULL
,	NULL
T.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1998	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
2949-2958	NULL
Tanaka	NULL
,	NULL
Y.	NULL
,	NULL
Inoi	NULL
,	NULL
T.	NULL
,	NULL
Tozawa	NULL
,	NULL
H.	NULL
,	NULL
Yamamoto	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
86	NULL
,	NULL
549-555	NULL
Miura	NULL
,	NULL
S.	NULL
,	NULL
Ohtani	NULL
,	NULL
K.	NULL
,	NULL
Numata	NULL
,	NULL
N.	NULL
,	NULL
Niki	NULL
,	NULL
M.	NULL
,	NULL
Obbo	NULL
,	NULL
K.	NULL
,	NULL
Ina	NULL
,	NULL
Y.	NULL
,	NULL
Gojobori	NULL
,	NULL
T.	NULL
,	NULL
Tanaka	NULL
,	NULL
Y.	NULL
,	NULL
Tozawa	NULL
,	NULL
H.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
1313-1325	NULL
Paterson	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Jefferies	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
Green	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Brandon	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Corthesy	NULL
,	NULL
P.	NULL
,	NULL
Puklavec	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Williams	NULL
,	NULL
A.	NULL
F.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Immunol	NULL
.	NULL

24	NULL
,	NULL
1281-1290	NULL
Baum	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Gayle	NULL
,	NULL
R.	NULL
B.	NULL
r.	NULL
,	NULL
Ramsdell	NULL
,	NULL
F.	NULL
,	NULL
Srinivasan	NULL
,	NULL
S.	NULL
,	NULL
Sorensen	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Watson	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Seldin	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Baker	NULL
,	NULL
E.	NULL
,	NULL
Sutherland	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Clifford	NULL
,	NULL
K.	NULL
N.	NULL
,	NULL
Alderson	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Goodwin	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
and	NULL
Franslow	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
3992-4001	NULL
Godfrey	NULL
,	NULL
W.	NULL
R.	NULL
,	NULL
Fagnoni	NULL
,	NULL
F.	NULL
F.	NULL
,	NULL
Harara	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Buck	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Engleman	NULL
,	NULL
E.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180	NULL
,	NULL
757-762	NULL
Stuber	NULL
,	NULL
E.	NULL
,	NULL
Neurath	NULL
,	NULL
M.	NULL
,	NULL
Calderhead	NULL
,	NULL
D.	NULL
,	NULL
Fell	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
and	NULL
Strober	NULL
,	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
507-521	NULL
Higashimura	NULL
,	NULL
N.	NULL
,	NULL
Takasawa	NULL
,	NULL
N.	NULL
,	NULL
Tanaka	NULL
,	NULL
Y.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

87	NULL
,	NULL
227-281	NULL
Mallett	NULL
,	NULL
S.	NULL
,	NULL
Fossum	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Barclay	NULL
,	NULL
A.	NULL
N.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
1063-1068	NULL
Smith	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Farrah	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Goodwin	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
959-962	NULL
Allen	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Armitage	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Conley	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Rosenblatt	NULL
,	NULL
H.	NULL
,	NULL
Jenkins	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Copeland	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
Bedell	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Edelhoff	NULL
,	NULL
S.	NULL
,	NULL
Disteche	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Simoneaux	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
Fanslow	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Belmont	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Springgs	NULL
,	NULL
M.	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
259	NULL
,	NULL
990-993	NULL
Aruffo	NULL
,	NULL
A.	NULL
,	NULL
Farrington	NULL
,	NULL
M.	NULL
,	NULL
Hollenbaugh	NULL
,	NULL
D.	NULL
,	NULL
Li	NULL
,	NULL
X.	NULL
,	NULL
Milatovich	NULL
,	NULL
A.	NULL
,	NULL
Nonoyama	NULL
,	NULL
S.	NULL
,	NULL
Bajorath	NULL
,	NULL
J.	NULL
,	NULL
Grosmaire	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Stenkamp	NULL
,	NULL
R.	NULL
,	NULL
Neubauer	NULL
,	NULL
M.	NULL
,	NULL
Roberts	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Nuelle	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Francke	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Ochs	NULL
,	NULL
H.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
72	NULL
,	NULL
291-300	NULL
DiSanto	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Bonnefoy	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
Gauchat	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Fischer	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
de	NULL
Saint	NULL
Basile	NULL
,	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
361	NULL
,	NULL
541-543	NULL
Stuber	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Strober	NULL
,	NULL
W.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
,	NULL
979-989	NULL
Sugamura	NULL
,	NULL
K.	NULL
,	NULL
Fujii	NULL
,	NULL
M.	NULL
,	NULL
Kannagi	NULL
,	NULL
M.	NULL
,	NULL
Sakitani	NULL
,	NULL
M.	NULL
,	NULL
Takeuchi	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Inf	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
84	NULL
,	NULL
221-228	NULL
Miyoshi	NULL
,	NULL
I.	NULL
,	NULL
Kubonishi	NULL
,	NULL
I.	NULL
,	NULL
Yoshimoto	NULL
,	NULL
S.	NULL
,	NULL
Akagi	NULL
,	NULL
T.	NULL
,	NULL
Ohtsuki	NULL
,	NULL
Y.	NULL
,	NULL
Shiraishi	NULL
,	NULL
Y.	NULL
,	NULL
Nagata	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Nature	NULL
294	NULL
,	NULL
770-771	NULL
Kaplan	NULL
,	NULL
J.	NULL
,	NULL
Tilton	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Peterson	NULL
,	NULL
W.	NULL
D.	NULL
,	NULL
Jr.	NULL
(	NULL
1976	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Hematol	NULL
.	NULL

1	NULL
,	NULL
219-223	NULL
Ohtani	NULL
,	NULL
K.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Saito	NULL
,	NULL
S.	NULL
,	NULL
Nagata	NULL
,	NULL
K.	NULL
,	NULL
Sugamura	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
1589-1604	NULL
Sakitani	NULL
,	NULL
M.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Fujii	NULL
,	NULL
M.	NULL
,	NULL
Sugamura	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Virus	NULL
Genes	NULL
1	NULL
,	NULL
85-47	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

HTLV-I	NULL
Tax-mediated	NULL
Activation	NULL
Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
Ohtani	NULL
,	NULL
K.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Saito	NULL
,	NULL
S.	NULL
,	NULL
Noda	NULL
,	NULL
T.	NULL
,	NULL
Ito	NULL
,	NULL
Y.	NULL
,	NULL
Sugamura	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
389-395	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Niki	NULL
,	NULL
M.	NULL
,	NULL
Nagata	NULL
,	NULL
K.	NULL
,	NULL
Ohtani	NULL
,	NULL
K.	NULL
,	NULL
Saito	NULL
,	NULL
S.	NULL
,	NULL
Hinuma	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
20189-20192	NULL
Akagi	NULL
,	NULL
T.	NULL
,	NULL
Ono	NULL
,	NULL
H.	NULL
,	NULL
Nyunoya	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Shimotohno	NULL
,	NULL
K.	NULL
(	NULL
1997	NULL
)	NULL
Oncogene	NULL
14	NULL
,	NULL
2071-2078	NULL
Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Virology	NULL
187	NULL
,	NULL
316-320	NULL
Gunning	NULL
,	NULL
P.	NULL
,	NULL
Leavitt	NULL
,	NULL
J.	NULL
,	NULL
Muscat	NULL
,	NULL
G.	NULL
,	NULL
Ng	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
and	NULL
Kedes	NULL
,	NULL
L.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
4881-4885	NULL
60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

14129	NULL
.	NULL

Numata	NULL
,	NULL
N.	NULL
,	NULL
Ohtani	NULL
,	NULL
K.	NULL
,	NULL
Niki	NULL
,	NULL
M.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
New	NULL
Biologist	NULL
8	NULL
,	NULL
896-906	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
Cogswell	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
3964-3974	NULL
Kaszubska	NULL
,	NULL
W.	NULL
,	NULL
Hooft	NULL
van	NULL
Huijsduijnen	NULL
,	NULL
R.	NULL
,	NULL
Ghersa	NULL
,	NULL
P.	NULL
,	NULL
DeRaemy-Schenk	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Chen	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
Hai	NULL
,	NULL
T.	NULL
,	NULL
DeLamarter	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Whelan	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
7180-7190	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Herrlich	NULL
,	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
3879-3891	NULL
Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
921-928	NULL
Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
826	NULL
,	NULL
711-713	NULL
of	NULL
the	NULL
gp34	NULL
Gene	NULL
Promoter	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Molecular	NULL
Mechanisms	NULL
of	NULL
Promoter	NULL
Regulation	NULL
of	NULL
the	NULL
gp34	NULL
Gene	NULL
That	NULL
Is	NULL
Trans-activated	NULL
by	NULL
an	NULL
Oncoprotein	NULL
Tax	NULL
of	NULL
Human	NULL
T	NULL
Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
I	NULL
Kiyoshi	NULL
Ohtani	NULL
,	NULL
Atsumi	NULL
Tsujimoto	NULL
,	NULL
Tomonori	NULL
Tsukahara	NULL
,	NULL
Noboru	NULL
Numata	NULL
,	NULL
Shigeto	NULL
Miura	NULL
,	NULL
Kazuo	NULL
Sugamura	NULL
and	NULL
Masataka	NULL
Nakamura	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1998	NULL
,	NULL
273:14119-14129.	NULL
doi	NULL
:	NULL
10.1074/jb0.273.23.14119	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/273/23/14119	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
65	NULL
references	NULL
,	NULL
30	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

